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“Ignorance more frequently begets confidence than does knowledge: it is 
those who know little, and not those who know much, who so positively 
assert that this or that problem will never be solved by science.” 
 
Charles Darwin 
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Resumo 
A infertilidade é definida como a incapacidade de alcançar uma gravidez viável após 12 ou 
mais meses de relações sexuais regulares não protegidas e estima-se que afete, 
aproximadamente, 10 a 15% da população mundial. Os fatores masculinos, isolados ou em 
combinação com os fatores femininos, são conhecidos por contribuir para a infertilidade e, 
apesar das suas principais causas ainda serem reportadas como idiopáticas, nos homens, 
15% dos casos podem ser atribuídos a anomalias genéticas. A hiperviscosidade do sémen 
(SHV) e a astenozoospermia (AST) são dois fenótipos predominantes de infertilidade 
masculina, mas muito menos explorados de um ponto de vista genético do que outros 
fenótipos menos comuns. Vários elementos-chave foram descritos como possíveis causas de 
SHV e AST, incluindo infeções urogenitais, inflamação e aumento de níveis de espécies 
reativas de oxigênio (ROS). 
Anteriormente, o nosso grupo realizou um estudo de sequenciação completa do exoma 
(WES) em 71 pacientes portugueses com infertilidade masculina, que incluíam fenótipos de 
SHV e AST. Nesse estudo, duas regiões genómicas foram identificadas como estando 
possivelmente associadas à infertilidade masculina, incluindo o gene inibidor de crescimento 
induzido pelo stress oxidativo 1 (OSGIN1) e o locus do antigénio leucocitário humano (HLA), 
mais especificamente o gene HLA-DRB5. Enquanto o OSGIN1 codifica uma proteína com 
função na regulação do stress oxidativo (OS) e morte celular, o locus HLA codifica uma série 
de glicoproteínas com funções especializadas na regulação do sistema imune. Portanto, para 
explorar a hipótese de uma maior suscetibilidade aos fenótipos SHV e AST ligados à variação 
do OSGIN1 e do HLA-DRB5, foi realizada uma pesquisa num grupo extenso de casos e 
controlos de infertilidade (160 e 55, respetivamente). Para este propósito, foram utilizados 
diferentes métodos de sequenciação de Sanger e PCR para a genotipagem da variação do 
OSGIN1 e do HLA-DRB5, várias ferramentas bioinformáticas e bases de dados para abordar 
o impacto funcional e a significância estatística das potenciais associações com a infertilidade 
masculina. 
Na avaliação do sinal de associação do OSGIN1, concluímos que este era um falso positivo 
resultante do desalinhamento das reads do WES devido a uma região repetitiva complexa. 
Ainda assim, foi possível identificar uma variante comum (p.Ala357Ala - rs3743627) que se 
verificou ser estatisticamente significativo na análise clássica da associação caso-controlo 
com o fenótipo AST. Além disso, verificou-se que 4 variantes de baixa frequência estavam 
sobre-representados em pacientes com AST e/ou SHV (p.Val540Ala - rs62640905; 
p.Phe308Phe - rs201940808; p.Pro341Pro - rs142802229 e c.*193G> A - rs534233458). 
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Naturalmente, todas estas 5 variantes estavam localizadas numa região do OSGIN1 
contendo um local de ligação para o fator de transcrição POLR2A o que poderá afetar a 
expressão génica. 
O sinal de associação do HLA-DRB5 revelou ser outro exemplo de um falso positivo, desta 
vez relacionado com o desalinhamento das reads do WES devido à ocorrência de 
polimorfismo do número de cópias no locus HLA. Além disso, a maioria dos casos e controlos 
não contém o gene HLA-DRB5 (fINF = 0.1039 e fCON = 0.0741), não evidenciando qualquer 
ligação à doença. Na análise da variabilidade do HLA-DRB5, o alelo HLA-DRB5*01:08N/02 
destacou-se por ter uma frequência considerável em SHV e AST, dada a sua ausência nos 
controlos. Estudos adicionais com um maior número de amostras de casos e controlos podem 
ser necessários para compreender melhor a existência de uma possível correlação deste 
grupo de alelos de HLA-DRB5 com a infertilidade masculina. 
 
 Palavras-chave: genética humana; estudos de associação; variação de 
sequenciação de DNA; métodos de sequenciação de larga escala e Sanger; OSGIN1; HLA-
DRB5  
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Abstract 
Infertility is defined as the inability to achieve a viable pregnancy after 12 or more months of 
regular unprotected sexual intercourse and is estimated to affect approximately 10-15% of the 
worldwide population. Male factors, either alone or in combination with female factors, are 
known to contribute to infertility and even though, its main causes are still reported as 
idiopathic, in males, 15% of cases can be attributed to genetic anomalies. Semen 
hyperviscosity (SHV) and asthenozoospermia (AST) are two prevalent male infertility 
phenotypes much less explored from a genetic standpoint than others less common. Several 
key elements have been advanced as possible sources for SHV and AST including urogenital 
infections, inflammation and increase levels of reactive oxygen species (ROS). 
Previously, our team performed a whole-exome sequencing (WES) study in 71 Portuguese 
male infertility patients, comprising SHV and AST phenotypes. There, two genomic regions 
were identified as possibly associated to male infertility, these included the oxidative stress-
induced growth inhibitor 1 (OSGIN1) gene and the human leukocyte antigen (HLA) locus, 
more specifically the HLA-DRB5 gene. Whereas OSGIN1 encodes a protein with roles in the 
regulation of oxidative stress (OS) and cell death, the HLA locus encodes a series of 
glycoproteins with specialized functions in the regulation of immune system. Therefore, to 
explore the hypothesis of an increased susceptibility to SHV and AST phenotypes linked to 
OSGIN1 and HLA-DRB5 variation, we performed a screening in an extended cohort of 
infertility cases and controls (160 and 55, respectively). For this purpose, we used different 
PCR and Sanger sequencing methods for genotyping of OSGIN1 and HLA-DRB5 variation 
and several bioinformatics tools and databases to address functional impact and statistical 
significance of potential associations to male infertility. 
In the evaluation of OSGIN1 association signal, we concluded that it was a false positive 
resulting from WES reads misalignments to a complex repeat region. Still, we could identify a 
common variant (p.Ala357Ala – rs3743627) found to be statistically significant in the classic 
case-control association analysis with AST phenotype. Furthermore, 4 low-frequency variants 
were found to be overrepresented in AST and/or SHV patients (p.Val540Ala – rs62640905; 
p.Phe308Phe – rs201940808; p.Pro341Pro – rs142802229 and c.*193G>A – rs534233458). 
Most interestingly, all 5 variants were located in a OSGIN1 region containing a binding site for 
POLR2A transcript factor possibly affecting gene expression. 
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The association signal of HLA-DRB5 turned out to be another example of a false positive, this 
time correlated with WES reads misalignments due to the occurrence of copy number 
polymorphism in HLA locus. Moreover, we found that most cases and controls lack HLA-DRB5 
gene (fINF = 0.1039 and fCON = 0.0741), not evidencing any linking to disease. In the analysis 
of HLA-DRB5 variability the allele HLA-DRB5*01:08N/02 stood out by a considerable 
frequency in SHV and AST given its absence in controls. Studies in extended samples of 
cases and controls may be necessary to disentangle a possible correlation of this HLA-DRB5 
allele group with male infertility. 
 
Keywords: human genetics; association studies; DNA sequencing variation; High-throughput 
and Sanger sequencing methods; OSGIN1; HLA-DRB5   
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Infertility is a worldwide problem and, according to the International Committee for Monitoring 
Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO), it is 
defined as the inability to achieve a viable pregnancy after 12 or more months of regular 
unprotected sexual intercourse (WHO 1999, 2010; Zegers-Hochschild, et al. 2017). This 
reproductive health issue is estimated to affect approximately 10-15% of global population and 
it can be caused either by male or female factors or a combination of both (Li, et al. 2014). 
Although about 50% of couples are infertile due to both female and male factors, in nearly 
30% of cases, the infertility causes are exclusively associated with males (Agarwal, et al. 
2015). However, in some instances, the cause of infertility cannot be determined and these 
can be classified as cases of unexplained male infertility (UMI) or idiopathic male infertility 
(IMI). The main difference between these male infertility types relies on the semen analysis: 
in UMI semen parameters are expected to be within normal reference values, whereas in IMI 
one or more parameters are frequently found to differ from such established thresholds 
(Hamada, et al. 2011). The prevalence of IMI accounts for 10-15% of cases, whereas the 
prevalence of UMI ranges from 6-27% (Hamada, et al. 2011; Gudeloglu, et al. 2014; Leaver 
2016).  
Broadly speaking, when a couple is confronted with a diagnosis of infertility, distinct medical 
reproductive procedures can be advised to overcome the disease. In this context, different 
assisted reproductive techniques (ART) were developed over the latest decades and have 
contributed to a significant increase in the reproductive success rates of infertility patients. 
Nevertheless, these MAP methods are often associated to high economic, emotional and 
physical burdens and thus, a considerable proportion of couples never initiate treatment or 
quit after a few failed attempts (Bromer and Seli 2008). Taking into account the magnitude of 
this reproductive issue, it demands urgent, innovative and less invasive responses by scientific 
and medical communities. More specifically and concerning male infertility, despite several 
years of research devoted to the field, many of the causes leading to abnormal semen 
parameters remain unknown or poorly understood and consequently, lack appropriate 
diagnosis and treatment. Importantly, prior to exploring the molecular causes of male infertility 
it is fundamental to understand the organization of the male reproductive system, namely its 
regular anatomy and physiology, as well as the biological processes underlying the formation 
of spermatozoa and semen composition. 
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1.1 The Male Reproductive System 
The male reproductive system is mainly composed by testes, several accessory glands 
(prostate, seminal vesicles and bulbourethral glands) and the male copulatory organ, the 
penis. Anatomically, a testis is a complex system of genital ducts (seminiferous tubules and 
epididymis) responsible for spermatozoa production (spermatogenesis) (Figure 1) 
(Silverthorn, et al. 2012; Young, et al. 2013; Sherwood 2015). Briefly, a testis is divided into 
250-300 compartments that basically include the seminiferous tubules surrounded by 
interstitial tissue. These two elements of the testis are distinct at structural and functional 
levels: the interstitial tissue is consisted mainly by Leydig cells, stimulated by the luteinizing 
hormone (LH) and responsible for testosterone production - the main male sex hormone; the 
seminiferous tubules, on the other hand, are highly coiled structures, in which the germline 
cells are embedded and supported by Sertoli cells. The Sertoli cells are stimulated by 
testosterone and follicle stimulating hormone (FSH) to support the spermatogenesis 
(Silverthorn, et al. 2012; Young, et al. 2013; Sherwood 2015). 
 
Figure 1 – Anatomical organization of the male reproductive system (left) and testis structure (right). The male 
reproductive system is composed by testes, accessory glands (prostate, seminal vesicles and bulbourethral glands) and the 
penis. Each testis comprises a complex system of genital ducts (seminiferous tubules and epididymis) responsible for 
spermatozoa production and maturation, respectively. (Figure adapted from Sherwood 2015).  
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1.1.1 Spermatogenesis 
The biological process of spermatogenesis can be divided into three main stages: 
spermatogoniogenesis (mitotic proliferation), spermatocytogenesis (meiotic division) and 
spermiogenesis (post-meiotic differentiation) (Silverthorn, et al. 2012; Young, et al. 2013; 
Sherwood 2015). All these phases occur in the testis, more specifically in the seminiferous 
tubules, later followed by a process of sperm maturation in the epididymis.  
In the first stage of spermatogenesis (spermatogoniogenesis),  the spermatogonia (a diploid 
stem cell) initiates the mitotic divisions giving rise, on one hand, to type A spermatogonia, 
which mainly maintains the pool of germline cells, and on the other, to type B spermatogonia 
that will differentiate into primary spermatocytes (diploid cells) (Figure 2) (Silverthorn, et al. 
2012; Young, et al. 2013; Sherwood 2015). Before the second stage of spermatogenesis, the 
primary spermatocytes migrate into the adluminal compartment of the seminiferous tubules. 
Later, already in the second stage (spermatocytogenesis), each primary spermatocyte 
undergoes a first meiotic division originating two secondary spermatocytes, which after a 
second meiotic division originate four spermatids (haploid cells) (Silverthorn, et al. 2012; 
Young, et al. 2013; Sherwood 2015). 
 
Figure 2 – First stages of spermatogenesis. Schematic representation of cell differentiation from spermatogonia to 
spermatids (left) and tissue spatial localization of sperm cell differentiation (right). Spermatogonia give origin to type A and 
type B spermatogonia. The later one will differentiate into primary spermatocytes (mitotic proliferation). Then the primary 
spermatocytes migrate into the adluminal compartment of seminiferous tubules and undergo a first meiotic division originating 
the secondary spermatocytes, which after a second meiotic division generate the spermatids. (Figure adapted from Sherwood 
2015). 
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Finally, in the third stage (spermiogenesis), the spermatids differentiate into highly specialized 
cells, the spermatozoa. In this later stage of spermatogenesis, the spermatozoa undergo 
several differentiation steps that culminate into three major structures: the head, the midpiece 
and the tail or flagellum (Figure 3) (Silverthorn, et al. 2012; Young, et al. 2013; Sherwood 
2015). In short, the head contains the nucleus, where the chromatin is organized in a 
condensed structure and the acrosome (Sherwood 2015). The latter is located in the anterior 
extremity of the head and functions as a protective shell and as a critical element for oocyte 
penetration. The acrosome also contains several enzymes, such as hyaluronidase PH-20 and 
acrosin that aids in the penetration of the outermost oocyte layer (corona radiata) and 
hydrolyse the zona pellucida, respectively (Young, et al. 2013; Sherwood 2015). The posterior 
region of the spermatozoa head is then occupied by centrioles that allow the flagellum 
formation through the organization of a microtubules network - the axoneme. Even though the 
tail is the structure responsible for spermatozoa motility, this is only possible due to the 
presence of mitochondria in the midpiece that produce energy as adenosine triphosphate 
(ATP).  
Once spermatogenesis is completed and spermatozoa fully differentiated, these are stored in 
the epididymis until the moment of ejaculation. Still, the epididymis is more than a simple 
repository of sperm cells, as it also contributes to the final maturation steps, in which 
spermatozoa acquire further motility and fertilizing abilities (Silverthorn, et al. 2012; Sherwood 
2015). 
 
Figure 3 – Main structural features of a mature human spermatozoa. The head contains the nucleus and the acrosome. The 
tail comprises a network of microtubules that allow spermatozoa motility. The midpiece contains a large number of mitochondria 
essential for energy production. (Figure adapted from Anton and Krawetz 2012). 
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1.1.2 Semen Composition 
The semen can be subdivided into two major fractions: a cellular fraction that primarily 
contains sperm cells and the seminal plasma. The latter is an assorted mixture of fluids 
secreted by the seminal vesicles, prostate, testes (mainly epididymis) and bulbourethral 
glands (Silverthorn, et al. 2012; Young, et al. 2013; Sherwood 2015). This biological fluid, the 
seminal plasma, provides many essential nutrients and important molecules to spermatozoa 
protection in the female reproductive environment, namely against acidic pH, immune 
response and bacterial attack (Du Plessis, et al. 2013). Precisely, the seminal vesicles 
produce a viscous and alkaline liquid, which contributes to 45-70% of the volume of the 
seminal fluid and it also includes important elements for sperm function. Seminal vesicles 
secreted substances comprise: (1) fructose, which is used as the primary energy source for 
spermatozoa; (2) prostaglandins, that are responsible for stimulating smooth muscle 
contraction in male and female reproductive systems, helping spermatozoa transport; (3) 
fibrinogen, a precursor of fibrin that forms a three-dimensional protein network corresponding 
to the base of the seminal coagulum and (4) semenogelins (SEMGs), also responsible for the 
formation of the seminal coagulum, which captures and protects spermatozoa (Silverthorn, et 
al. 2012). 
The prostate contributes with 15-30% of the seminal fluid including: (1) prostate specific 
antigen (PSA) and other trypsin and chymotrypsin-like enzymes, that have key roles in semen 
liquefaction and spermatozoa motility, (2) citric acid, which confers energy, nutritional and 
antibacterial advantage, and (3) zinc, an important cofactor for proteolytic enzymes with 
functions in the semen liquefaction (Silverthorn, et al. 2012; Du Plessis, et al. 2013). 
The testicular and epidydimal fractions include mainly sperm cells and other secreted 
substances, such as testosterone and inhibin (hormone control), contributing with less than 
5% of the seminal fluid volume. Finally, the bulbourethral glands contribute with 1-5% of the 
seminal fluid and are responsible for the secretion of mucus (mucoproteins) that acts as a 
lubricant during sexual intercourse, facilitates ejaculation of the seminal fluid and neutralizes 
the acid environment in the male urethra and vagina (Silverthorn, et al. 2012). 
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These secretions are mixed during ejaculation and, immediately, semen proteins undergo 
cross-linking and turning semen into a coagulum in which the spermatozoa are entrapped. 
This semen coagulation process is mainly dependent of proteins derived from seminal vesicle 
secretions. Approximately 20-30 minutes later, semen liquefaction is expected to occur mainly 
through the activity of PSA and other substances secreted by prostate (Lilja and Laurell 1984). 
Changes in semen composition can have negative effects in male fertility, either by a direct 
impact on spermatozoa or indirectly by altering seminal plasma properties. Therefore, a 
semen analysis (spermiogram) is routinely used in reproductive medicine to address male 
fertility status and possibly disclose reproductive failures in male infertile patients. 
 
1.2 Evaluation of Semen Quality 
Semen quality is determined according to reference values that if not fulfilled can render a 
subject to be classified into one or more infertility phenotypes (WHO 1999, 2010). Importantly, 
reference thresholds were recently revised by WHO, giving rise in most instances to abnormal 
semen parameters with narrower intervals and with consequences in the classification of male 
infertility cases (WHO 2010). However, these novel guidelines are not consensual among 
clinicians, partially due to the allocation of former infertility cases with confirmed reproductive 
failure into the category of normal subjects (Esteves, et al. 2012; Agarwal, et al. 2015). 
Notwithstanding, both versions of WHO guidelines advise an initial and detailed evaluation of 
causes for male reproductive failure (WHO 1999, 2010). This should comprise first a complete 
appraisal of subject medical history, together with a physical examination, followed by a 
spermiogram (semen analysis). Typically, the later routine analysis includes an evaluation of 
semen volume, sperm concentration and total counts, pH, viscosity, liquefaction, motility, 
morphology and presence of white blood cells (Table I). 
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Table I – Threshold values for a normal spermiogram according to WHO guidelines (WHO, 1999, 2010). 
Parameter Reference value (1999) Reference value (2010) 
Volume ≥ 2.0 mL ≥ 1.5 mL 
Sperm concentration ≥ 20 million per mL ≥ 15 million per mL 
Total sperm count ≥ 40 million per ejaculate ≥ 39 million per ejaculate 
pH ≥ 7.2 ≥ 7.2 
Viscosity ≤ 2cm thread length ≤ 2cm thread length 
Liquefaction Complete until 60 minutes Complete until 60 minutes 
Sperm Motility 
≥ 50% with progressive (rapid 
and slow) motility 
Or 
≥ 25% with rapid progressive 
motility 
≥ 40% total (progressive and non-
progressive) motility 
Or 
≥ 32% progressive (rapid and slow 
motility) 
Sperm Morphology ≥ 14% with normal forms1 ≥ 4% with normal forms 
White blood cells ≤ 1 million per mL ≤ 1 million per mL 
1 Recommended value, since was not yet defined a limit value for this parameter. 
 
Different infertility phenotypes may be defined according to the above WHO reference values 
(WHO 1999, 2010): 
1) Aspermia: absence of an ejaculated product; 
2) Azoospermia (AZO): absence of spermatozoa in the ejaculate;  
3) Oligozoospermia (OLI): spermatozoa count bellow threshold value; 
4) Semen Hyperviscosity (SHV): increased semen viscosity as inferred by the 
presence of a thread longer than the threshold value; 
5) Asthenozoospermia (AST): spermatozoa motility bellow threshold value; 
6) Teratozoospermia (TER): spermatozoa with normal morphology below the 
threshold value; 
7) Leukospermia (LEU): number of white blood cells in the ejaculate above the 
threshold value. 
Among these phenotypes, AZO cases can be further subdivided into obstructive azoospermia 
(OA) and non-obstructive azoospermia (NOA), if the cause for absence of sperm cells can be 
attributed to an obstruction of genital ducts, or instead if it results from an inability to produce 
spermatozoa, respectively (Leaver 2016).  
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In this scope, SHV can be assessed by the traditional WHO criteria through the length in 
centimetres of a thread formed after pipetting semen that was left to liquefy over 60 minutes 
(WHO 1999, 2010). Furthermore, abnormal viscosity can be subdivided according to the 
thread length into: mild (2-4 cm), moderate (4-6 cm) and severe SHV (≥ 6 cm) (Elia, et al. 
2009). Recently, a more quantitative method that requires the use of a capillary-loaded 
viscosimeter is started to be implemented specially in research orientated projects. In such 
case, semen viscosity is measured by the time taken by the sample to completely fill the 
capillary (La Vignera, et al. 2012). This method is considered to be a more accurate, but it also 
implies the availability of larger semen volumes, is more time consuming and involves a 
specific equipment (La Vignera, et al. 2012; Du Plessis, et al. 2013). 
Whenever semen parameters are found to deviate from reference values, the spermiogram is 
recommended to be repeated 1-3 months after the initial analysis, to avoid possible false 
positives cases. However, even after repeating the spermiogram, about 90% of male infertility 
cases still show one or more seminal abnormalities (Leaver 2016). This means that different 
male infertility phenotypes, such as SHV, AST, OLI and TER are not mutually exclusive and 
may coexist in the same individual. The identification of single or multiple abnormal 
phenotypes are considered as an evidence for male infertility, in which each phenotype can 
have diverse origins by diverse intrinsic and extrinsic factors. 
 
1.3 Factors Associated with Male Infertility 
Several factors have been associated with male infertility including testicular pathologies (e.g. 
varicocele and cryptorchidism); post-testicular features and sexual dysfunction (e.g. 
retrograde or premature ejaculation and erectile dysfunction); hormonal dysregulation (e.g. 
hypogonadism and hypothyroidism); urogenital infections (e.g. prostatitis and urethritis); 
ageing; comorbidity with other complex diseases (e.g. obesity and diabetes); emotional stress; 
toxins and drugs (e.g. smoking, alcohol and anabolizing steroids). Additionally, major and 
minor genetic anomalies (chromosomal abnormalities and large structural variants and point 
mutations, respectively), usually evaluated in routine genetic screenings, may also be 
associated with male infertility (Table II) (Jungwirth, et al. 2012; Leaver 2016; Stevenson, et 
al. 2016). 
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Table II – Most common causes of male infertility. 
Testicular 
Factors 
Hormonal 
Factors 
Urogenital 
Infections 
Social and 
Environmental 
Factors 
Genetic Causes 
 
Varicocele 
 
Cryptorchidism 
 
Trauma / 
Torsion 
 
Testicular tumor 
 
Hypospadias 
Hypogonadism 
 
 
Hypothyroidism 
 
 
Hypothalamus 
dysfunction 
Prostatitis 
 
 
Urethritis 
Emotional 
stress 
 
Smoking 
(e.g. tobacco 
and marijuana) 
 
Alcohol 
 
Excessive heat 
exposure 
 
Exposure to 
pesticides and 
heavy metals 
(e.g. mercury) 
 
Exposure to 
radiation and 
drugs 
(e.g. steroids, 
immune and 
chemotherapy) 
Klinefelter 
syndrome 
(47, XXY) 
 
 
Jacobs 
syndrome 
(47, XYY) 
 
 
Y chromosome 
microdeletions 
 
 
Cystic fibrosis 
mutations 
(CFTR) 
Post Testicular 
Factors 
Sexual 
Dysfunction 
Physiological and 
Metabolic Factors 
Ducts 
obstruction 
 
Retrograde 
ejaculation 
Premature 
ejaculation 
 
Erectile 
dysfunction 
Age 
 
Obesity 
 
Diabetes 
 
1.3.1 Genetic Causes of Male Infertility 
Despite the genetic basis of male infertility continues largely unexplained, in up to 15% of 
cases it can be attributed to genetic anomalies. More specifically, in OLI and AZO up to 13% 
of males have been reported to carry numerical and structural chromosomal abnormalities, 
involving either sex chromosomes or autosomes (Durak Aras, et al. 2012; Pizzol, et al. 2014). 
Among these, the most well-known causes for male infertility are the Klinefelter (47, XXY) and 
Jacobs (47, XYY) syndromes, which are both sex chromosome abnormalities. Indeed, the 
prevalence of Klinefelter syndrome reach 5-10% in OLI and AZO phenotypes (Jungwirth, et 
al. 2012; Pizzol, et al. 2014; Neto, et al. 2016). Other genetic causes for male infertility 
involving the sex chromosomes are Y microdeletions, mainly those occurring in the long arm 
and in a region named as “azoospermic factor” (AZF), which is further subdivided into three 
loci: AZFa, AZFb, AZFc. Such microdeletions encompassing AZF loci are reported to account 
for 10-15% of azoospermic cases and 5% of severe oligozoospermic cases (Poongothai, et 
al. 2009; Pizzol, et al. 2014; Neto, et al. 2016).  
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The most important genetic cause for male infertility involving autosomes is the occurrence of 
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene 
(chr7:117120017-11730871) encoding an anion channel essential for salt homeostasis, which 
aside from being associated with cystic fibrosis can be also connected to male infertility (Neto, 
et al. 2016). Point mutations affecting CFTR function are relatively common in populations of 
European ancestry (1/25), where males with mild mutations may exhibit reproductive 
malformations, such as bilateral or unilateral absence of the vas deferens (Poongothai, et al. 
2009; Jungwirth, et al. 2012; Neto, et al. 2016). Specifically, congenital bilateral absence of 
the vas deferens are found in about 1% of overall infertility cases up to 25% in OA. On the 
other hand, CFTR mutations can also affect spermatogenesis and sperm maturation, but the 
molecular mechanisms behind this dysfunction still need further clarification (Neto, et al. 
2016). 
AZO and OLI are the most investigated infertility phenotypes present in approximately 15% 
and 30% of male infertility cases, respectively (Bak, et al. 2010; Wosnitzer, et al. 2014). 
However, there are other prevalent phenotypes that may occur together or independently of 
low spermatozoa numbers, such as SHV and AST and that are much less explored from a 
genetic standpoint. 
 
1.4 The Semen Hyperviscosity (SHV) Phenotype  
SHV is estimated to have a prevalence ranging from 12% to 29% and to negatively impact 
sperm function and semen quality (Du Plessis, et al. 2013). Several factors have been 
proposed to contribute to SHV, namely through an altered processing of the semen coagulum. 
For instance, semenogelins (SEMG1 and SEMG2) and kallikreins (KLKs) have been 
implicated in the dysregulation of the cascade of semen coagulation and liquefaction in SHV 
(Mendeluk, et al. 2000; Lzanaty, et al. 2004; Marques, et al. 2016). In a healthy status, SEMGs, 
the two major structural semen proteins are involved in the coagulation and spermatozoa 
immobilization, while KLKs, especially KLK3 (also known as PSA) participate in the 
liquefaction process as serine proteases (Lilja, et al. 1987; Robert, et al. 1997; Lzanaty, et al. 
2004; Marques, et al. 2016). Other important factors playing a role in semen coagulation are 
zinc, which is crucial in modulating SEMGs protein network and fructose that forms complexes 
with the coagulum proteins (Robert, et al. 1997; Andrade-Rocha 2005). In this context, high 
SEMGs and fructose levels and low concentrations of KLKs and zinc have been hypothesized 
as a factor for the SHV phenotype. 
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Urogenital infections are another potential source for SHV. These infections are usually 
associated in a reasonable number of cases with sexually transmitted pathogens, such as 
Neisseria gonorrhoeae, Chlamydia trachomatis and Herpes Simplex Virus. However, male 
genitourinary infections can also be originated by other type of microorganisms, more 
frequently found in the gastrointestinal tract, like the bacteria Escherichia coli (Table III) 
(Ochsendorf 2008; Pellati, et al. 2008; Schuppe, et al. 2017). In such circumstances, mild SHV 
cases may be then treated with similar procedures to sexually transmitted diseases (antibiotics 
and anti-inflammatory drugs). One the other hand, these therapeutics are only either 
unsuccessful or partially effective when applied to severe SHV cases given that these only 
reduce their phenotype from severe to moderate or mild SHV (Elia, et al. 2009). Although the 
information concerning the implications of bacterial and/or viral pathogens in the SHV 
phenotype is practically non-existent, it is well accepted that different infectious agents may 
damage prostate and seminal vesicle, hence altering the semen composition (Monteiro 2015). 
 
Table III – Most prevalent pathogens associated to urogenital infections and male infertility. 
Infectious Agent Associated Pathology Relevance in Infertility 
Bacteria 
Neisseria gonorrhoeae 
Chronic urethritis 
Epididymitis 
Orchitis 
↑ Bacterial-spermatozoa 
Adhesion (sperm motility) 
 
↑ Alterations in Accessory 
Glands and Urethra (obstruction) 
 
↓ Seminal Fluid Quality 
Chlamydia trachomatis 
Chronic urethritis 
Epididymitis 
Orchitis 
Escherichia coli Chronic Bacterial Prostatitis 
Ureaplasma urealyticum 
Urethritis 
Prostatitis 
Epididymitis 
Mycoplasma genitalium 
Urethritis 
Prostatitis 
Virus 
Herpes Simplex Virus 
(HSV) 
Prostatitis 
Epididymitis 
↓ Seminal Fluid Quality 
 
↓ Sperm Quality (motility, 
morphology, sperm count) Human Papillomavirus 
(HPV) 
Urethritis 
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Furthermore, urogenital infections and inflammation of the accessory glands can be also 
connected to elevated numbers of seminal leukocytes, LEU phenotype, even though patients 
with LEU not always show clear evidence of infection (Elia, et al. 2009; Rusz, et al. 2012). 
Macrophages and polymorphonuclear (PMN) granulocytes are the predominant leukocyte 
types observed in LEU, which are reported to alter spermatozoa motility and molecular 
structure, but also seminal viscosity (Domes, et al. 2012; Castiglione, et al. 2014; Flint, et al. 
2014). In addition, elevated leukocyte levels contribute to a further increase in inflammatory 
state by realising cytokines, like interleukin-6 (IL-6) produced by macrophages that can be 
found at high concentrations in patients with accessory gland inflammation as well as in SHV 
(La Vignera, et al. 2012; Castiglione, et al. 2014). 
Leukocytes are also an important source of reactive oxygen species (ROS) that, once 
augmented in semen, may contribute to abnormal ROS levels (Ko, et al. 2014). Importantly, 
human spermatozoa are also able to produce different ROS, such as hydrogen peroxide 
(H2O2), superoxide anion (O2-) and hydroxide (OH), which are harmful to spermatozoa 
themselves due to the interference with polyunsaturated fatty acids from the plasma 
membrane (Fraczek and Kurpisz 2007; Ko, et al. 2014). To protect sperm cells from the toxic 
effect of ROS, seminal plasma contains antioxidants (ROS scavengers), such as 
superoxidase dismutase (SOD) and catalase (CAT). Still, whenever there is an imbalance 
between ROS production and degradation by ROS scavengers this will result in an increased 
oxidative stress (OS) (Ko, et al. 2014). Interestingly, the SHV phenotype has been correlated 
with high levels of OS as a possible consequence of sperm membrane lipid peroxidation (LPO) 
or low antioxidant capacity of the semen (Siciliano, et al. 2001; Henkel, et al. 2005; Aydemir, 
et al. 2008; Layali, et al. 2015). 
Another likely explanation for SHV is a change in seminal protein-protein interactions. For 
example, malondialdehyde (MDA) is an end-product of lipid peroxidation that decreases 
protein solubility, thus modifying seminal viscosity (Aydemir, et al. 2008). On the other hand, 
OS also promotes the formation of disulphide bonds between proteins normally enrolled in 
seminal clot networking, thus also being potentially correlated with SHV (Mendeluk, et al. 
2000). Finally, the genetic variability of seminal proteins may as well play a role in the 
development of the SHV phenotype. Indeed, a few rare KLK and SEMG variants were 
associated to male infertility and SHV (Marques, et al. 2016). In addition, CFTR mutations 
causing cystic fibrosis can, along with the production of a sticky mucus in the lungs, change 
the semen characteristics, namely by increasing its viscosity (Rossi, et al. 2004). Therefore, 
SHV can be as well considered as a minor clinical presentation of cystic fibrosis. 
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1.5 The Asthenozoospermia (AST) Phenotype 
The AST phenotype is estimated to account for 18-20% of infertility cases alone and together 
with other conditions, such as OLI, TER and SHV it can surpass more than 50% (Curi, et al. 
2003; Wang, et al. 2009). Several factors have been proposed to contribute to AST, including 
once again urogenital infections associated to C. trachomatis, E. coli, Ureaplasma urealyticum 
and Mycoplasma genitalium bacteria (Table III) (Rusz, et al. 2012). Briefly, all these infectious 
agents are thought to reduce spermatozoa motility through their binding to sperm cells, 
resulting not only in a significant decrease of sperm membrane potential as well as in 
spermatozoa agglutination (Diemer, et al. 2003; Pellati, et al. 2008; Schuppe, et al. 2017). 
Herpes Simplex Virus (HSV) and Human Papillomavirus (HPV) infections were also correlated 
with AST, since sperm motility was found to be significantly decreased in affected patients 
(Kapranos, et al. 2003; Yang, et al. 2013). 
Similar to the SHV phenotype, AST can be also associated with LEU and inflammation, in 
which sperm cell function and integrity may be affected by ROS, in response to an increment 
of cytokine levels. Essentially, leukocyte products are believed to damage spermatozoa 
flagellum contributing to a reduction of sperm cell motility (Plante, et al. 1994; Armstrong, et 
al. 1999; Henkel 2011). In addition, inflammatory processes in the male reproductive tract are 
recognized to generate anti-sperm antibodies that can be linked to lower motility rates, given 
that such antibodies can cause spermatozoa agglutination and/or immobilization (Dimitrov, et 
al. 1994; Curi, et al. 2003). On the other hand, increased ROS can lead to loss of sperm 
membrane fluidity, decrease protein phosphorylation and consequently cause the 
immobilization of sperm cells (Figure 4) (de Lamirande and Gagnon 1992; Agarwal, et al. 
2003; Athayde, et al. 2007; Agarwal, et al. 2014). Such phenomenon is connected with the 
production of H2O2, which diffuses across the sperm membrane inhibiting the activity of 
several enzymes, such as glucose-6-phosphate dehydrogenase (G6PD). In this context, the 
decrease of NADPH availability (source of electrons to ATP production) as a result of G6PD 
inhibition originates a depletion of the metabolic energy and a reduction in spermatozoa 
antioxidant defences (Armstrong, et al. 1999; Agarwal, et al. 2003). 
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Figure 4 – Mechanisms and/or consequences of ROS in spermatozoa. Increased ROS can lead to apoptosis in maturing 
germ cells, which ultimately damages deoxyribonucleic acid (DNA), proteins and lipids, with or without caspase activation. In 
addition, ROS leads to increased OS, which decrease protein phosphorylation and sperm function. Altogether these phenomena 
compromise male fertility. (Figure from Ko, el al. 2014). 
 
Furthermore, ROS is an end-product of oxidative phosphorylation (OXPHOS), a process that 
occurs in mitochondria for regular energy production (Benkhalifa, et al. 2014). Therefore, 
mitochondrial impairment by either structural or functional abnormalities, can be correlated 
with a decreased sperm motility (Piomboni, et al. 2012). For example, defects in the 
mitochondrial sheath can impact axoneme organization and mitochondrial respiratory chain 
activity, increasing membrane potential that may results in the reduced spermatozoa motility 
observed in AST patients (Piomboni, et al. 2012; Benkhalifa, et al. 2014). In addition, 
enhanced activity of mitochondrial enzymes was found in samples with lower spermatozoa 
motility (Cassina, et al. 2015). 
In normal physiological conditions, spermatozoa only acquire their motility after several 
maturation steps in the epididymis, in a biological process controlled by both extra and 
intercellular factors, such as calcium, kinases, phosphatases and osmolarity (Figure 5) 
(Luconi, et al. 2006). Calcium, the most important ion controlling human sperm motility, 
penetrates sperm cells through calcium channels present in the flagellum (e.g. CatSper 
channel), in which it is expected to modulate several enzymes from the calcium/calmodulin 
(CaM) complex (Singh and Rajender 2015; Williams, et al. 2015). In turn, CaM complex will 
stimulate sperm motility through a direct interaction with kinases and phosphatases. Then, in 
the sperm tail, phosphorylated proteins (tyrosine residues) will promote the molecular 
signalling for sperm movement activation (Luconi, et al. 2006). Hence, if the fine balance 
between kinases and phosphatases activities is disturbed, the tyrosine phosphorylation levels 
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are reduced and spermatozoa plasma membrane fluidity is altered, which ultimately leads to 
a decay in spermatozoa motility (Yunes, et al. 2003; Buffone, et al. 2005). 
Finally, during the maturation in the epididymis, spermatozoa acquire the ability to regulate 
their cell volume, which allows them to counteract the different osmolarities found during their 
transit from the testis to the ovary. In the epididymis, the sperm cells increase their uptake of 
osmolytes and organic compounds, such as amino acids that affect osmosis, to balance the 
higher osmolarity of the luminal fluid (Luconi, et al. 2006). Conversely, upon the ejaculation, 
they lose the acquired osmolytes to prevent swelling due to the lower osmotic pressure falls 
of the female genital tract. Defects in these processes may lead to abnormal sperm head 
volume and sperm tail angulation, and therefore alter sperm motility patterns (Luconi, et al. 
2006). 
 
Figure 5 – Extra and intracellular factors affecting the sperm motility. Calcium modulate several enzymes from the CaM 
complex, in which it will stimulate sperm motility through a direct interaction with kinases and phosphatases. Changes in the 
osmolarity itself or in the ability to regulate osmolarity pressures process (intra and extracellular) may lead to abnormal sperm 
head volume and sperm tail angulation. (Figure adapted from Luconi, et al. 2006). 
 
Importantly, SHV can also be a risk factor for lower spermatozoa motility (Lzanaty, et al. 2004). 
As previously mentioned, SEMGs are the major component of semen coagulum with important 
motility inhibitory properties. Therefore, a significant SEMGs increase may cause SHV 
phenotype entrapping the spermatozoa and change the sperm membrane potential through 
their binding to membrane proteins (Yoshida, et al. 2009; Mitra, et al. 2010; Yu, et al. 2014). 
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1.6 Genetic Susceptibility to Male Infertility 
Several genetic disorders are known to cause male infertility, but to date about 40% of genetic 
causes for reproductive failure remain unidentified (Krausz, et al. 2015). The search for genetic 
susceptibility to male infertility has been mainly focused on single nucleotide variants (SNVs), 
which involves a single nucleotide substitution in the DNA sequence. Such susceptibility 
variants can occur in regulatory regions, affecting gene expression, or in coding regions with 
expected repercussions in protein activity (mainly non-synonymous replacements) (Aston 
2014; Krausz, et al. 2015). 
In this scope, candidate gene approaches, which are based in case-control studies and in the 
screening of one or more genes selected a priori according to their biological, physiological, 
and functional relevance to male reproduction, allowed the identification of more than 100 
genes and SNVs significantly associated to male infertility (Krausz, et al. 2015; Marques, et 
al. 2016). Examples of such genes are methylenetetrahydrofolate reductase (MTHFR), 
deleted in azoospermia-like (DAZL) and estrogen receptor 1 and 2 (ESR1/ESR2) genes (Ge, 
et al. 2014; Gong, et al. 2015; Chen, et al. 2016). Nevertheless, candidate SNVs and genes 
are rarely concordant across independent studies, given that in most instances these were 
only evaluated in relatively small cohorts and not replicated by other researchers. Here, the 
amalgamation of samples with distinct ethnic/geographic origins may explain the low rates of 
replicated results (Aston 2014; Krausz, et al. 2015). 
More recently, genome-wide association studies (GWAS) enabled a screening for male 
infertility variants without any hypothesis driven investigation of cases and controls (Aston and 
Carrell 2009; Aston, et al. 2010; Hu, et al. 2011; Kosova, et al. 2012; Zhao, et al. 2012). In the 
last years, this approach allowed the identification of several unsuspected susceptibility genes 
for NOA, such as sex-determining region Y (SRY)-related high mobility group (HMG)-box gene 
5 (SOX5) and peroxisome biogenesis factor 10 (PEX10) genes as well as human leukocyte 
antigen-antigen D-related alpha chain (HLA-DRA) locus (Zhao, et al. 2012; Zou, et al. 2014). 
Still, once again low reproducibility rates were observed across independent studies and 
populations. 
Notably, the HLA locus turned out to be one of the most promising candidates, since a highly 
significant association with NOA phenotype has been reported by another study carried out in 
a Chinese sample (Zhao, et al. 2012) and later replicated in extended cohorts of Chinese and 
Japanese patients and controls (Jinam, et al. 2013; Hu, et al. 2014; Tu, et al. 2015; Zou, et al. 
2017). In a short explanation, the HLA locus is known to play an important role in the immune 
system by presenting peptides on the cell surface of antigen presenting cells, therefore, it is 
also commonly named as the human major histocompatibility complex (MHC) (Mosaad 2015). 
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1.6.1 Genetic Screening of 71 Portuguese Cases (SHV and AST) 
As mentioned above, SHV and AST are two correlated phenotypes often co-existing in the 
same sample that were only poorly investigated by candidate gene and GWAS approaches. 
To fill this gap, our team performed a whole-exome sequencing (WES) study in 71 Portuguese 
infertility patients displaying these two phenotypes either alone or together.  
In a brief overview of the used methodology, this survey was carried out by paired-end 
sequencing on an Illumina HiSeq Platform (Macrogen, Inc) with an average coverage of 30x, 
which comprised all known coding regions as well as 5’- and 3’-untranslated regions (UTRs). 
Then, sequenced reads were aligned against the human reference sequence (hg19) and 
variants annotated using an established pipeline comprising several standard tools (BWA, 
SAMtools, GATK, Picard and VCFtools). Next, identified variants were compared with 1000 
Genomes data for the Iberian population (IBS), which used as a control sample and as a 
source to sort SNVs according to their minor allele frequency (MAF). A 0.05 frequency was 
used to define common (MAF≥0.05) and low-frequency (MAF <0.05) variants. In a first 
analysis of common SNVs, two regions stood out by their potential significant associations 
with both SHV and AST phenotypes (Figure 6). Specifically, the two most promising male 
infertility candidates were the oxidative stress-induced growth inhibitor 1 (OSGIN1) gene and 
HLA-DRB5 locus. 
 
Figure 6 – Manhattan plot showing P-values for the WES association study under a simple case-control test. Genomic 
coordinates are displayed along the X-axis and the –log10 P-value for common variants (MAF ≥ 5%) are displayed on the Y-axis. 
Horizontal red line defines the threshold for Bonferroni significance (P-value = 3.9614 x10-7). The two most promising male 
infertility candidates OSGIN1 gene and HLA-DRB5 locus are highlighted in red. The X chromosome is coded as chromosome 
23. 
  
HLA OSGIN1 
MAF ≥ 5% 
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OSGIN1 gene, also known as ovary, kidney and liver protein 38 (OKL38) or bone marrow 
derived growth inhibitor (BDGI), is located on chromosome 16 (Figure 7) and it has been 
described to encode a protein that regulates the response to OS and cell death. In normal 
cells, OSGIN1 expression is mediated by nuclear factor E2-related (NRF2) transcription factor, 
where OSGIN1 protein may then inhibit the proliferation of cells exposed to OS (Li, et al. 2007). 
In addition, OSGIN1 can be as well regulated by the tumour suppressor p53, which can 
change gene activity from the nucleus to mitochondria, forcing OSGIN1 to induce apoptosis 
(Yao, et al. 2008; Hu, et al. 2012). Therefore, the loss or downregulation of OSGIN1 has been 
reported to promote tumour growth in different tissues, mainly in the liver (Ong, et al. 2007; 
Liu, et al. 2014). 
 
Figure 7 – Chromosome location and gene structure of OSGIN1. OSGIN1 is located on chromosome 16q23.3 and the three 
OSGIN1 isoforms are generated by alternative splicing, varying in coding exons numbers (organized in VI or VII exon structure). 
The shorter transcript shown in darker blue (ENST00000393306) is considered as the canonical isoform. 
 
The HLA locus, located on chromosome 6p21.32, encodes a large number of cell-surface 
glycoproteins specialized in the regulation of the immune system, being one of the most 
polymorphic regions known in the human genome (Mosaad 2015). Therefore, the HLA system 
follows a specific nomenclature for allele labeling, which is compiled at the IPD-IMGT/HLA 
Sequence Database and curated by the WHO Nomenclature Committee for Factors of the 
HLA System (Figure 8) (Marsh, et al. 2010; Robinson, et al. 2015). According to this 
nomenclature, HLA allele names have at least two and up to four sets of digits, in which the 
first set describes the allele group often corresponding to a serological antigen, the second 
reports specific HLA proteins variants and the following are used whenever needed to identify 
subtypes and are assigned by a sequence order of discovery (Marsh, et al. 2010). 
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Figure 8 – Nomenclature of HLA alleles. The first digits after gene name describe the allele group, the following digits are used 
to report specific protein variability features (field 2), the next ones are used to show alterations in coding sequence (field 3), and 
the final ones are used to show changes in non-coding regions (field 4). The suffix N denotes a null allele (absence of gene 
expression) (Figure from hla.alleles.org). 
 
Moreover, the HLA locus can also be divided into class I and II (Figure 9). Briefly, class I 
proteins comprise an alpha-chain encoded by HLA-A, -B or -C and a beta-chain encoded by 
β2-microglobulin (B2M) gene, located outside of HLA locus on chromosome 15 (Mosaad 
2015).  
 
Figure 9 – Schematic representation of HLA locus on chromosome 6p21.32. The HLA locus is divided into class I and II. 
Class I contains three major genes – HLA-A, -B, and -C. Class II contains five subloci – DP, DM, LMP/TAQ, DQ and DR and 
each of these subloci code for an alpha- and a beta-chain. (Figure adapted from Mosaad 2015). 
 
Class II molecules (Figure 9) comprise an alpha- and beta-chain and, specifically, the HLA-
DR sublocus comprises a fixed HLA-DRA, present in all individuals that is translated into a 
unique alpha-chain (Mosaad 2015). Moreover, this sublocus includes four functional genes 
coding for different beta-chains (HLA-DRB1, -DRB3, -DRB4 and -DRB5), in which HLA-DRB3-
5 genes may vary across individuals as copy number polymorphisms (Figure 10). On the other 
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hand, HLA-DRB1 is ubiquitous gene in human populations and with a considerable number of 
allele groups: HLA-DRB1*01 to HLA-DRB1*16, subdivided into an even larger number of 
specific alleles (e.g. HLA-DRB1*01:01:01 and HLA-DRB1*16:47) (Marsh, et al. 2010). 
Altogether, these contribute to the extensive variability of HLA-DR sublocus, exclusively 
provided by beta-chain genes. 
Furthermore, the organization of HLA-DRB genes in tandem on chromosome 6p21.32 region 
warrants the occurrence of strong linkage disequilibrium (LD) between alleles of different HLA-
DRB genes (Figure 10) (Andersson 1998; Norman, et al. 2017). For example, HLA-DRB5 
tends to segregate on the same haplotype (chromosome) together with either HLA-DRB1*15 
or HLA-DRB1*16 allele groups. Conversely, HLA-DRB3 gene is more often associated to 
HLA-DRB1*03 and HLA-DRB1*11-14 allele groups, and HLA-DRB4 is frequently linked to 
HLA-DRB1*04, HLADRB1*07 and HLA-DRB1*09. In addition, this HLA sub-region also 
contains several pseudogenes (HLA-DRB2 to HLA-DRB9) that may display as well some 
allelic diversity (Marsh, et al. 2010). 
 
Figure 10 – Major HLA-DR sublocus haplotypes found in human populations. Functional genes are displayed in bright 
colours (HLA-DRA, HLA-DRB1, HLA-DRB3-5) while pseudogenes are displayed in light grey (HLA-DRB2 to HLA-DRB9). HLA-
DRA (green) encodes the unique alpha-chain and HLA-DRB1 (magenta) encodes a type of beta-chain common to all HLA-DR 
haplotypes (fixed genes). The remaining genes – HLA-DRB3, HLA-DRB4 and HLA-DRB5 (lilac) coding for other beta-chain 
molecules are mutually exclusive and associated to a copy number polymorphism. The presence of HLA-DRB3-5 is often linked 
to particular allele groups of HLA-DRB1. (Figure adapted from Norman, et al. 2017). 
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Previous studies demonstrated that OSGIN1, encoding a protein with roles in the regulation 
of OS and cell death, and HLA locus, encoding for a series of glycoproteins with specialized 
functions in immunological control, could represent examples of association to male infertility. 
Therefore, to explore the hypothesis of an increased susceptibility to SHV and AST 
phenotypes linked to OSGIN1 and HLA (more specifically to HLA-DRB5) variation, we 
performed a screening of candidate regions in an extended sample of Portuguese infertility 
cases and controls. To achieve this main goal, we used different methodological approaches 
to address the following specific objectives: 
1. Sanger sequencing methods were used to genotype common and low-frequency 
variants of OSGIN1 potentially correlated with SHV and AST infertility phenotypes; 
2. Copy-specific PCR techniques, Sanger sequencing, IPD-IMGT/HLA Database and 
HLA*PRG:LA tool were combined to infer the HLA-DRB5 allelic variation;  
3. Fisher’s exact test and/or Burden and C-alpha tests were employed to evaluate the 
significance of variants association to male infertility. 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
3. Material and Methods 
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3.1 Biological Samples 
The sample size used in this study includes a total of 286 Portuguese subjects that have 
undergone a routine spermiogram analysis at Centro de Genética da Reprodução Prof. 
Alberto Barros or at Centro de Estudos de Infertilidade e Esterilidade. Briefly, peripheral blood 
or buccal swabs were collected after written informed consent and samples were 
accompanied by an informative registry of some semen parameters: liquefaction, viscosity, 
sperm concentration, motility and morphology. Samples were then stratified into cases and 
controls according to their spermiogram results and WHO 1999 guidelines for the above 
parameters. Additionally, cases were further subdivided into SHV and AST in agreement with 
the presence or absence of these phenotypes. Precisely, 111 and 188 samples were classified 
in SHV and AST, respectively, and a total of 69 cases were found to combine both phenotypes 
(Table IV). This sample also comprises the subset of 71 cases (61 SHV and 45 AST) 
previously analyzed in the WES study. 
 
Table IV – Sample collection scheme of male infertility cases and controls. 
Phenotype1 
Infertile Cases from 
WES Study (N = 71) 
Infertile Cases 
(N = 160) 
Total Infertile 
Cases (N = 231) 
Controls 
Semen Hyperviscosity2 61 50 111 -  
Oligozoospermia2 28 63 91 - 
Asthenozoospermia2 45 143 188 - 
Teratozoospermia2 37 79 116 - 
Normozoospermia - - - 55 
WES, whole-exome sequencing study 
1 According to WHO 1999 guidelines, except for TER for which it was used the WHO 2010 guidelines. 
2 The four abnormal phenotypes are not mutually exclusive, that is, the same individual may be included in distinct phenotype 
groups. For simplicity, SHV and AST, the two phenotypes addressed in this study, will be treated as independent variables. 
 
All samples had been previously processed for DNA collection. Shortly, genomic DNA from 
peripheral blood was extracted using the Genomic DNA Purification Kit (Citogene) according 
to manufacturer’s instructions and DNA from buccal swabs through BuccalAmp DNA 
Extraction Kit (Epicenter) following the standard protocol. 
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3.2 Polymerase Chain Reaction (PCR) Amplification 
Candidate regions of OSGIN1 and HLA-DRB5 were selected for PCR amplification using 
specific primer pairs (Table V). Exactly, OSGIN1 candidate regions were divided into four main 
fragments (Figure 11A): the first one included exon I and part of intron I (1698bp); the second 
fragment also included exon I and part of intron I without a repeat region (1303bp); the third 
amplicon included a short segment of intron I (451bp) containing a repeat region and the last 
one comprised exon VII (1508bp). 
For HLA-DRB5, two amplicons were designed (Figure 11B): one included exon II (887bp) and 
was used for HLA-DRB5 allele typing; and the other covered the genomic region from exon III 
to exon VI (2238bp) and was used, together with the previous fragment, to determine the 
presence or absence of HLA-DRB5 copy number polymorphism. 
 
Table V – Regions analyzed for OSGIN1 and HLA-DRB5, including primer sequences and PCR conditions. 
Gene 
Candidate 
Region 
Primers Sequences (5’ – 3’)1 PCR Cycle Conditions 
OSGIN1 
Exon I and 
Intron I 
Fw – CTCAAGTCAGCCTGCAAAGA 
Rv – TCATGTGTGCATGTGTGTGC 95ºC 5 min 
 
35 cycles (95ºC 30seg, 
65ºC 5seg, 68ºC 1:30min) 
 
68ºC 20 min 
Exon I and 
Intron I (R1) 
Fw – CTCAAGTCAGCCTGCAAAGA2 
Rv – TGCCAGTGCTGGCAGTAAGG2 
Intron I (R2) 
Fw – GCTTCTCATTGTGCTCCCTAA2 
Rv – CATGTGCTCACGTGTGCATG2 
Exon VII 
Fw – ACAGCCTAGTCCAGCTCCAG2 
Rv – GACCTCATCCAGGACCACAT2 
HLA-DRB5 
Exon II 
Fw – CTAAACCTTCACCCCAACCA2 
Rv – CTTGGGATCAGAAGGGGTTT 
95ºC 5 min 
 
10 cycles (95ºC 10seg, 
59ºC 30seg, 68ºC 2 min) 
 
25 cycles (95ºC 10seg, 
57ºC 30seg, 68ºC 2 min) 
 
68ºC 20 min 
Exon III to 
Exon VI 
Fw – GCCAGGTGGACAGATGATT 
Rv – GTATCCTGCAAGGACCCAGA 
Fw, forward primer; Rv, reverse primer 
1 All primers were used in PCR reactions at a concentration of 0.5µM. 
2 All primers were used in the sequencing reactions of their corresponding fragments. 
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A. OSGIN1 gene (chr16) – ENST00000343939 
 
 
 
 
5’                          3’ 
 
 
 
B. HLA-DRB5 gene (chr6) – ENST00000374975 
 
 
 
 
3’                5’ 
 
 
Figure 11 – Schematic representation of the strategy used for the amplification of OSGIN1 (A) and HLA-DRB5 (B) 
candidate regions. On top is shown the position of OSGIN1 or HLA-DRB5, and below is shown the exons/introns organization 
of OSGIN1 or HLA-DRB5, respectively. Exons are represented as full boxes and introns by lines. Arrows indicate the amplicons 
used for genetic surveying of candidate regions. Length of each gene (chr16:83982672-83999937 and chr6:32485154-32498006) 
and amplicon in base pairs (bp) is indicated (human reference sequence GRCh37/hg19 assembly). 
 
3.3 DNA Electrophoresis in Agarose Gels 
PCR amplifications of target OSGIN1 and HLA-DRB5 segments were evaluated by 
electrophoresis in 1.5% agarose gels, using SGTB Buffer 1x (GRISP) commercial buffer and 
GreenSafe Premium (Nzytech) as a fluorescence dye for DNA. The PCR products were 
visualized by Gel Doc XR+ System (Biorad). 
Telomere Centromere 
p21.32 
72 460bp 
q23.3 
17 266bp 
Centromere Telomere 
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3.4 Purification of PCR Products and Sanger Sequencing 
Prior to Sanger sequencing, amplified segments of OSGIN1 and HLA-DRB5 were column 
purified using Sephacryl S-300 High Resolution (GE Healthcare) resin to remove primers, 
unincorporated dNTPs and enzymes from PCR reactions. Purified samples were then used in 
the sequencing reaction with BigDye Terminator Sequencing version 3.1 cycle sequencing 
chemistry (Applied Biosystems) and specific primers at a concentration of 0.25µM (see point 
2 at Table V footnote). Afterward, sequencing products were column purified with Sephadex 
G-50 Fine DNA Grade (GE Healthcare) resin and Hi-Di Formamide (Applied Biosystems) was 
added before the electrophoretic analysis in an ABI3130 automated sequencer (Applied 
Biosystems). 
 
3.5 Sequence and Expression Data Analysis 
OSGIN1 sequences were assembled against NG_029757.1 sequence deposited in the 
National Center for Biotechnology Information (NCBI) Database (www.ncbi.nlm.nih.gov/). We 
selected this reference sequence for sequence variation analysis because it considers the 
largest predicted isoform (ENST00000343939).  
All sequences were aligned using Geneious 5.2 software and all putative variants were 
manually curated to minimize sequencing errors. Functional consequences of all identified 
variants were inferred using Variant Predictor Effect (VEP) tool from Ensembl Genome 
Browser 80 (grch37.ensembl.org/Homo_sapiens/Tools/VEP), which incorporates SIFT and 
Polyphen scores for non-synonymous protein substitutions (Kumar, et al. 2009; Adzhubei, et 
al. 2010; McLaren, et al. 2016). Briefly, while SIFT predicts the variation effect based on 
sequence homology (conservation), PolyPhen, on the other hand, predicts the variation effect 
based on phylogenetic and structural considerations. In addition, chromatin segmentation and 
Chip-Seq data from ENCODE Project was also inspected using the University of California, 
Santa Cruz (UCSC) Genome Browser (genome.ucsc.edu/) to assess if SNVs were located at 
any known regulatory region (Kent, et al. 2002; Rosenbloom, et al. 2013). 
In the analysis of HLA-DRB5 data, collected sequences were first assembled against 
NG_002432.1 sequence deposited in the NCBI database using Geneious 5.2 software to 
confirm the presence of HLA-DRB5 and inspect its sequence variation. Moreover, the HLA-
DRB5 allele typing was accomplished by submitting the obtained sequences to IPD-
IMGT/HLA Database (www.ebi.ac.uk/ipd/imgt/hla/), which is a repository for all HLA 
sequences reported so far, through its Basic Local Alignment Search Tool (BLAST) engine 
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(www.ebi.ac.uk/ipd/imgt/hla/blast.html) (Robinson, et al. 2015). In addition, the HLA*PRG:LA 
tool was applied to the infertile WES dataset and also to 55 controls, from which WES data 
was meanwhile obtained, to infer the HLA alleles at high resolution. The allele information for 
HLA-DRB1, HLA-DRB3 and HLA-DRB4 were extracted from this latter analysis, since it helps 
to infer/confirm the presence or absence of HLA-DRB5 (Dilthey, et al. 2016). 
Additionally, OSGIN1 expression levels were evaluated through the Genotype-Tissue 
Expression (GTEx) portal (www.gtexportal.org/home/). This database provides information 
about gene/transcript expression across different tissues and its correlation to the genetic 
variation – expression quantitative trait loci (eQTL) (Carithers, et al. 2015; Wang, et al. 2016). 
 
3.6 Statistical Analysis 
Two statistical approaches were used to assess the possible association of identified variants 
with male infertility phenotypes (SHV and/or AST). First, all variants were divided according to 
their MAF in the 1000 Genomes Project for Iberian sample into common (MAF ≥ 0.05) or low-
frequency (MAF < 0.05) variants. 
For common OSGIN1 and HLA-DRB5 variants, significance of frequency differences between 
cases and controls were evaluated using two-tailed Fisher’s Exact Test in the GraphPad 
Software (www.graphpad.com/). For low-frequency variants of OSGIN1, a possible 
enrichment of deleterious variants (missense, UTR and splice region) was tested using C-
alpha Test (Neale, et al. 2011) and Burden Test implemented in the PLINK/SEQ package 
v0.10 (atgu.mgh.harvard.edu/plinkseq/). 
In all circumstances, three sets of comparisons were carried out to take into account possible 
associations to a specific phenotype (SHV or AST) and to male infertility more generally 
(SHV+AST). Exactly, these comprise the comparisons of controls against SHV and AST 
phenotype, separately, and the control group against all cases (SHV + AST). Additionally, to 
empower the statistical analyses for association, the Sanger sequencing and WES datasets 
were combined and analyzed together. The analysis of low-frequency variants was only 
performed in the combined dataset. 
  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
4. Results and Discussion 
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A preliminary analysis of our WES study in a cohort of 71 Portuguese infertility patients was 
performed by comparing the allele frequencies of identified SNVs with the data available from 
the 1000 Genomes project (phase3) for an Iberian population (see also chapter 1 section 
1.6.1). 
Two loci were identified as potentially associated with SHV and AST phenotypes: OSGIN1 
and HLA-DRB5 (Figure 6, in chapter 1). Hence, to explore these two signals of association to 
male infertility, we first evaluated the accuracy of variant calling by carrying out a Sanger 
sequencing survey in selected cases of the WES cohort. Then, the genotyping of these two 
loci was extended to an independent cohort of 160 infertile cases (50 SHV e 143 AST) and 55 
normozoospermic (controls with regular spermiogram parameters). In the end, to increase the 
statistical power of this study, a combined analysis was performed in an extended cohort 
(WES & Sanger) comprising a maximum of 231 infertility cases. 
 
4.1 Analysis of OSGIN1 Association Signal 
Two genomic regions were analyzed in OSGIN1: a first one surrounding exon I, given that this 
emerged as a likely candidate with three SNVs showing significant p-values in the WES study; 
and a second region surrounding exon VII, since it presented a considerable number of low-
frequency variants. 
At an initial stage of our study, 10 cases of the WES cohort were randomly selected to be 
Sanger sequenced to confirm variant calling and WES results. In a first approach, in the 
genotyping of exon I region (sequencing of an amplicon with 1698bp - chr16:83982558-
83984255), we found a large discrepancy between WES and Sanger genotypes that could be 
attributed to a repeat region located in intron I. Taking into consideration that these regions 
tend to be difficult to analyze by both sequencing methods, WES (Illumina 100bp read 
misalignments) and Sanger (polymerase slippage during PCR), we decided to divide this 
region into two overlapping fragments: an amplicon of 451bp (R2: chr16:83982558-83983860) 
spanning the identified repeat stretch, and another amplicon of 1303bp (R1: chr16:83983480-
83983930) excluding this region (Figure 11A, in chapter 2). Still, even after this subdivision of 
the target region, the genotypes of the three SNVs contained in the repeat fragment remained 
discrepant between WES and Sanger sequencing methods (Figure 12). 
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Figure 12 – Example of a repeat region alignment between the reference sequence and Sanger sequencing 
chromatogram. The reference sequence is shown on top in color. The green bar represents the sequence homology between 
the reference and chromatogram, in which differences are in yellow. Variants are illustrated as orange squares. The red boxes 
indicate the three SNVs with significant p-values detected in the WES study. Genotypes obtained for the same sample with 
Sanger sequencing and WES methods are shown below in green boxes. 
 
In this context, it is well known that repetitive regions may represent a technical challenge in 
studies using NGS techniques due to their short length of the reads (~100bp) leading to 
misalignments and errors in variant calling (Treangen and Salzberg 2012; Li and Freudenberg 
2014). Briefly, these issues arise often when reads are able to align at multiple locations in the 
reference sequence, producing a scenario often called as multi-reads. For example, if two 
repeat regions present high homology in the reference sequence, we expect to have low 
confidence in read mapping, because reads can align randomly across both regions (Figure 
13A) (Treangen and Salzberg 2012). This limitation may subsequently affect variant calling 
through the generation of false positives and negatives. For example, if two repeat units are 
imperfect and differ by one base when reads are wrongly aligned to the reference sequence 
these can create the illusion of a variant – false positive (Figure 13B). One the other hand, if 
a sequence variant turns the repeat unit more alike to a distinct segment of the reference, then 
the variant may fail to be detected – false negative. 
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Figure 13 – Alignment of multi-reads into different locations (repeat regions) in the reference sequence, trough NGS 
technology. If two repeat regions present 100% homology (A), we expect to have low confidence in read mapping, because 
reads can align randomly across both regions. If two repeat units present 98% homology differing by one or two bases (B), the 
reads may end up wrongly aligned creating the illusion of a variant – false positive (Figure adapted from Treangen and Salzberg 
2012). 
 
Additionally, repeat regions may also represent a technical challenge in studies using Sanger 
sequencing. Here, the most common flaws are associated to polymerase slipped-strand 
mispairing during PCR, often called as “slippage” (Clarke, et al. 2001), which causes repeat 
numbers to expand and contract, generating a pool of amplicons varying in size. Furthermore, 
if the repeat number is itself polymorphic a wide range of amplicons can be obtained in which 
smaller fragments tend to be overrepresented. Once again, if repeats are imperfect it can be 
extremely difficult to disentangle whether the observed sequence “variation” is real or an 
artifact generated by PCR. 
Accordingly, the three SNVs with significant p-values could in fact be false positives, since 
they are all located in a repeat region (Figure 12). More importantly, the overlapping segment 
of amplicons R1 and R2 included three variants upstream of the repeat region, which allowed 
us to evaluate accordance of WES and Sanger results and to discriminate between potential 
faults caused by read misalignments or PCR. In most instances, we could separate 
WES/Sanger results into three situations: 1) cases in which PCR amplification of the repeat 
region failed – a SNV allele was lost in R1 and R2 fragments, but present in the inferred WES 
genotype; 2) cases in which WES error were detect – a SNV allele identified in both R1 and 
R2 fragments was absent from the inferred WES genotype and; 3) ambiguous cases – 
opposite alleles for the same SNV were identified by Sanger (R1 and R2) and WES methods. 
In the end, we decided to exclude all repeat region variation from our analysis thus, losing the 
three common OSGIN1 candidate SNVs from WES study, due to the low confidence on the 
genotyping results obtained in such segment. 
A B 
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4.1.1 OSGIN1 Variability and Association to Male Infertility  
Upon the exclusion of the repeat segment, only exon I SNVs comprised in the R1 fragment 
and exon VII sequence (amplicon with 1508bp - chr16:83998556-84000063) were used to 
evaluate the OSGIN1 association to SHV and AST phenotypes. A total of 33 variants were 
identified: 12 common and 21 low-frequency (Tables VI and VII, respectively). 
In a first general analysis of the common variants, there were 5 that stood out for their 
localization and potential functional consequences (Table VI): c.-95C>T (5’UTR mutation); 
c.*41A>G and c.*205T>C (3’UTR mutations); c.738-5A>G (splicing region variant); and 
p.Pro6Leu (nonsynonymous mutation). However, none of these variants differed statistically 
in cases and controls comparisons. Still, another SNV emerged as a promising candidate due 
to its statistical significance in a set of case-control association tests. Oddly, this was found to 
be a synonymous mutation (c.1071C>G – p. Ala357Ala). Precisely, this variant found to be 
statistically significant in the analysis of Sanger sequencing as well as in the combined 
analysis (Sanger & WES), in the comparison of AST phenotype versus NRM (P-value Sanger = 
0.0214 and P-value Sanger&WES = 0.0266). According to Chip-seq data from ENCODE, the 
p.Ala357Ala (rs3743627) variant in spite of being a synonymous mutation is located in a 
regulatory region that harbors binding sites for ribonucleic acid (RNA) polymerase II subunit A 
(POLR2A) and B-cell CLL/lymphoma 3 (BCL3) transcription factors (Figure 14). POLR2A is 
the largest subunit A of RNA polymerase II, responsible for synthesizing the messenger RNA 
(mRNA) in eukaryotes. This variant may therefore affect the binding of POLR2A transcription 
factor to a regulatory region of OSGIN1, thus influencing its expression, overall levels of OS 
and ultimately male fertility. 
 
 
 
 
 
 
 
Figure 14 – OSGIN1 distribution of binding sites for different transcription factors and SNVs. OSGIN1 exon-intron 
organization is shown on the top, where the first isoform denotes the selected transcript (ENST00000343939) for annotation 
purposes. All SNVs and binding sites for transcription factors identified by Chip-seq (ENCODE) are shown below. SNVs detected 
in our study are indicated by black boxes and yellow vertical lines. Red box highlights exon VII region comprising the 6 surveyed 
SNVs rs3743627, rs62640905, rs111436159, rs201940808, rs142802229 and rs534233458. 
POLR2A 
BCL3 
 Table VI – Common variants of OSGIN1 identified among infertility cases and controls. 
SNV ID 
Nucleotide 
Substitution1 
MAF - cases MAF - controls 
Pathogenicity 
Prediction 
WES Sanger2 WES & Sanger 
NRM 
N = 55 
IBS 
N = 107 
SIFT 
(score) 
PolyPhen 
(score) Total 
N = 71 
AST 
N = 45 
SHV 
N = 61 
Total 
N = 158 
AST 
N = 141 
SHV 
N = 49 
Total 
N = 229 
AST 
N = 186 
SHV 
N = 110 
rs2432561 g.83982670G>A 0.1972 0.2111 0.2213 0.1551 0.1454 0.2041 0.1681 0.1613 0.2136 0.1909 0.1306 NA NA 
rs4782864 c.-95C>T 0.4296 0.4333 0.4262 0.3956 0.3830 0.4694 0.4061 0.3952 0.4455 0.3727 0.3360 NA NA 
rs4782865 
c.17C>T 
(p.Pro6Leu) 
0.4296 0.4333 0.4262 0.3956 0.3830 0.4490 0.4061 0.3952 0.4455 0.3455 0.3320 
Tolerated low 
confidence 
(0.07) 
Benign 
(0.007) 
rs2245009 c.57+600G>A NS NS NS 0.1456 0.1383 0.1735 NA NA NA 0.1909 0.1310 NA NA 
rs2245008 c.57+644G>A NS NS NS 0.1677 0.1631 0.2042 NA NA NA 0.1636 0.1780 NA NA 
rs12933677 c.57+664T>C NS NS NS 0.4367 0.4397 0.3878 NA NA NA 0.4273 0.4580 NA NA 
rs733728 c.738-5A>G 0.1901 0.1778 0.2131 0.1582 0.1598 0.1745 0.1681 0.1640 0.1955 0.2273 0.2150 NA NA 
rs3743627 
c.1071C>G 
(p.Ala357Ala) 
0.0704 0.0667 0.0738 0.0570 0.0461 0.0816 0.0611 0.0511 0.0773 0.1182 0.0560 NA NA 
rs173776 
c.1104A>G 
(p.Ser368Ser) 
0.2394 0.2111 0.2705 0.2184 0.2163 0.2653 0.2249 0.2151 0.2682 0.2727 0.2290 NA NA 
rs35132222 
c.1332C>A 
(p.Leu444Leu) 
0.1831 0.2000 0.1639 0.1582 0.1525 0.1745 0.1659 0.1640 0.1682 0.1091 0.1540 NA NA 
rs77204347 c.*41A>G 0.1479 0.1333 0.1393 0.1108 0.1170 0.0816 0.1223 0.1210 0.1136 0.1182 0.0980 NA NA 
rs4782574 c.*205T>C 0.1761 0.1889 0.1885 0.1930 0.2057 0.1837 0.1878 0.2016 0.1864 0.2636 0.1920 NA NA 
SNV, single nucleotide variant; MAF, minor allele frequency; WES, whole-exome sequencing; AST, asthenozoospermia; SHV, semen hyperviscosity; NRM, 
normozoospermia; IBS, Iberian populations in Spain from 1000 Genomes project; N, number of individuals; NA, not applicable; NS, not surveyed 
1 The longest transcript (ENST00000343939) was chosen for variant annotation purposes. 
2 Some samples were excluded from the analysis due to missing or uncompleted genotypes. 
Underlined allele frequencies represent the variant rs3743627 statistically significant for the set of comparisons (AST with NMR) under Fisher’s exact test. The significant nominal p-values (P < 0.05) were 0.0214 and 
0.0266, respectively. 
 Table VII – Low-frequency variants of OSGIN1 identified among infertility cases and controls. 
SNV ID 
Nucleotide 
Substitution1 
MAF - cases MAF - controls 
Pathogenicity 
Prediction 
WES Sanger2 WES & Sanger 
NMR 
N = 55 
IBS 
N = 107 
SIFT 
(score) 
PolyPhen 
(score) Total 
N = 71 
AST 
N = 45 
SHV 
N = 61 
Total 
N = 158 
AST 
N = 141 
SHV 
N = 49 
Total 
N = 229 
AST 
N = 186 
SHV 
N = 110 
rs58056773 c.-343G>C 0.0282 0.0444 0.0246 0.0316 0.0355 0.0306 0.0306 0.0376 0.0273 0.0182 0.0140 NA NA 
rs74478878 
c.32G>A 
(p.Arg11Gln) 
0.0000 0.0000 0.0000 0.0032 0.0036 0.0000 0.0022 0.0027 0.0000 0.0000 0.0000 
Tolerated low 
confidence 
(0.36) 
Benign 
(0.00) 
rs73245090 c.57+46G>C NS NS NS 0.0095 0.0106 0.0000 NA NA NA 0.0000 0.0050 NA NA 
rs73245092 c.57+213A>C NS NS NS 0.0063 0.0071 0.0102 NA NA NA 0.0000 0.0000 NA NA 
rs74032327 c.57+253C>A NS NS NS 0.0222 0.0213 0.0204 NA NA NA 0.0182 0.0140 NA NA 
rs74032328 c.57+285G>C NS NS NS 0.0253 0.0248 0.0204 NA NA NA 0.0273 0.0140 NA NA 
rs74032329 c.57+639C>G NS NS NS 0.0316 0.0319 0.0306 NS NS NS 0.0182 0.0140 NA NA 
rs80216064 c.57+692G>C 0.0352 0.0556 0.0328 0.0348 0.0319 0.0408 0.0349 0.0376 0.0364 0.0273 0.0140 NA NA 
rs116013542 c.57+696T>C 0.0070 0.0000 0.0082 0.0000 0.0000 0.0000 0.0022 0.0000 0.0045 0.0000 0.0050 NA NA 
rs114177454 c.57+697C>T 0.0070 0.0000 0.0082 0.0063 0.0071 0.0000 0.0066 0.0054 0.0045 0.0000 0.0050 NA NA 
rs767778426 
c.739G>A 
(p.Gly247Ser) 
0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0091 0.0000 
Tolerated 
(0.18) 
Possibly 
Damaging 
(0.816) 
rs76469730 
c.765C>T 
(p.Ala255Ala) 
0.0000 0.0000 0.0000 0.0032 0.0000 0.0102 0.0027 0.0000 0.0045 0.0091 0.0000 NA NA 
rs111436159 
c.789G>A 
(p.Arg263Arg) 
0.0070 0.0111 0.0082 0.0000 0.0000 0.0000 0.0022 0.0027 0.0045 0.0000 0.0000 NA NA 
                    Table VII: (Cont.) 
SNV ID 
Nucleotide 
Substitution1 
MAF - cases MAF - controls 
Pathogenicity 
Prediction 
WES Sanger2 WES & Sanger 
NMR 
N = 55 
IBS 
N = 107 
SIFT 
(score) 
PolyPhen 
(score) Total 
N = 71 
AST 
N = 45 
SHV 
N = 61 
Total 
N = 158 
AST 
N = 141 
SHV 
N = 49 
Total 
N = 229 
AST 
N = 186 
SHV 
N = 110 
rs201940808 
c.924C>T 
(p.Phe308Phe) 
0.0070 0.0111 0.0082 0.0000 0.0000 0.0000 0.0022 0.0027 0.0045 0.0000 0.0000 NA NA 
rs142802229 
c.1023C>T 
(p.Pro341Pro) 
0.0000 0.0000 0.0000 0.0032 0.0036 0.0102 0.0022 0.0027 0,0045 0.0000 0.0000 NA NA 
rs150791768 
c.1066G>A 
(p.Glu356Lys) 
0.0000 0.0000 0.0000 0.0032 0.0036 0.0000 0.0022 0.0027 0.0000 0.0000 0.0090 
Tolerated 
(0.06) 
Probably 
damaging 
(0.989) 
rs35145453 
c.1317G>T 
(p.Glu439Asp) 
0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0091 0.0000 
Tolerated 
(0.28) 
Benign 
(0.053) 
rs117872227 
c.1608C>T 
(p.Phe536Phe) 
0.0211 0.0111 0.0246 0.0000 0.0000 0.0000 0.0066 0.0027 0.0136 0.0000 0.0090 NA NA 
rs62640905 
c.1619T>C 
(p.Val540Ala) 
0.0282 0.0222 0.0328 0.0443 0.0426 0.0816 0.0393 0.0376 0.0545 0.0182 0.0190 
Tolerated 
(0.06) 
Possibly 
damaging 
(0.446) 
rs147251034 
c.1636G>A 
(p.Ala546Thr) 
0.0070 0.0111 0.0082 0.0032 0.0036 0.0000 0.0044 0.0054 0.0045 0.0091 0.0050 
Deleterious 
(0.00) 
Probably 
damaging 
(0.996) 
rs534233458 c.*193G>A 0.0000 0.0000 0.0000 0.0063 0.0071 0.0000 0.0044 0.0054 0.0000 0.0000 0.0000 NA NA 
SNV, single nucleotide variant; MAF, minor allele frequency; WES, whole-exome sequencing; AST, asthenozoospermia; SHV, semen hyperviscosity; NRM, normozoospermia; 
IBS, Iberian populations in Spain from 1000 Genomes project; N, number of individuals; NA, not applicable; NS, not surveyed 
1 The longest transcript (ENST00000343939) was chosen for variant annotation purposes. 
2 Some samples were excluded from the analysis due to missing or uncompleted genotypes. 
Variants marked in bold have a frequency two or more times higher in cases than in controls. Variants marked in italic and underlined are absent in from control groups NMR or IBS, respectively. 
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None of the identified intronic substitutions (c.57+600G>A, c.57+644G>A, c.57+664T>C and 
c.738-5A>G) were located in any regulatory region considering Chip-seq data from ENCODE. 
Nevertheless, the analysis of OSGIN1 transcriptional levels made available through the GTEx 
project allowed an evaluation of several testis eQTLs for OSGIN1. Indeed, a possible 
significant effect in OSGIN1 expression was disclosed for c.57+644G>A (rs2245008) variant. 
According to the eQTL plot for this variant (Figure 15) the G allele, found to be at 20% and 
16% frequencies in SHV and NRM, respectively, shows increases expression levels in testis. 
However, this would imply elevated OSGIN1 concentrations and an improved response to any 
imbalance in ROS production and degradation by ROS scavengers, leading most probably to 
a reduction of the OS in the testis (Ko, et al. 2014). Therefore, such positive effect discards 
an association of rs2245008 variant to SHV in correlation to OS levels. 
 
Figure 15 – eQTL data for c.57+644G>A (rs2245008) variant. Normalized values of OSGIN1 expression are displayed along 
the Y-axis and the genotypes (homozygous and heterozygous) are displayed on the X-axis. Box plots are shown as median and 
25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. The effect 
size of the eQTLs is computed as the effect of the alternative allele relative to the reference allele. Reference sequence contains 
minor allele. (Figure from www.gtexportal.org/home/). 
 
Concerning low-frequency variants, none reached significance in the statistical analyses 
performed for each SNV independently, as it would be expected from our limited sample size. 
Therefore, these SNVs were compiled altogether to evaluate whether there was an unusual 
enrichment of low-frequency variants in cases (combined dataset – Sanger & WES) compared 
to controls. This analysis was performed using C-alpha and Burden tests, but no clear 
evidence for excess of SNVs was detected. Nevertheless, 8 SNVs were identified as possible 
P-value = 6.0 x10-8 
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candidates given their absence in the control groups (NMR and IBS) or their discrepant 
frequencies between cases and NRM (increased more than two-fold) (Table VII). 
The c.-343G>C (rs58056773) variant was found to be overrepresented in infertile cases, 
particularly in AST cases (fAST = 0.0376), when compared with in controls (fNMR = 0.0182 and 
fIBS = 0.0140). Nevertheless, it is important to note that 6 infertile cases with AST phenotype 
also have SHV, which strengthens a possible link of AST and SHV phenotypes at least for this 
variant. In addition, this variant was also located in a regulatory region that harbors binding 
sites for multiple transcription factors, according to Chip-seq data from ENCODE (Figure 16). 
Among those was the transcription factor specificity protein 1 (SP1), which plays a role in 
several processes, such as cell growth, apoptosis, differentiation and DNA damage response. 
Furthermore, this transcription factor is known to bind to GC or GT box elements present in 
the promoter regions of genes involved in spermatogenesis and it has been shown to cause 
defects in embryonic development and to compromise male fertility if inactive (Thomas, et al. 
2007). Another transcription factor binding to this region is the histone deacetylase 2 (HDAC2) 
that regulates biological processes by deacetylation of histones and plays an important 
function in transcriptional regulation and cell cycle progression, whereas in male reproduction 
it is thought to protect primary spermatocytes against heat-stress. Therefore, any alterations 
in HDAC2 regulation may increase apoptosis and compromise male fertility (Li, et al. 2011). 
The androgen receptor (AR) was also found to bind to same genomic region of c.-343G>C 
(rs58056773) variant. The activity of AR transcription factor is mainly correlated with prostate 
development and is controlled by interactions between AR and forkhead box (FOX) 
transcription factors, particularly FOXA1, which can mediate prostate-specific gene 
expression (Grabowska, et al. 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 – OSGIN1 distribution of binding sites for different transcription factors and SNVs surrounding c.-343G>C 
(rs58056773) variant located in exon I. OSGIN1 exon-intron organization is shown on the top, where the first isoform denotes 
the selected transcript (ENST00000343939) for annotation purposes. All SNVs and binding sites for transcription factors identified 
by Chip-seq (ENCODE) are shown below. SNV detected in our study are indicated by yellow line. Red box highlights exon I 
region comprising the rs58056773. 
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Notably, this variant is also associated to a differential expression in the testis as uncovered 
by eQTLs data of GTEx project (Figure 17). In this case, the minor allele (C allele) seems to 
be have contrary effects in OSGIN1 compared to c.57+644G>A (rs2245008) variant (see 
above) consequently, it might have an impact in SHV and AST phenotypes connected with 
elevated OS levels. This seems to be contradictory to what would be supposed, since this 
variant in spite of being found at low-frequencies in our study, and in other population of 
European origin, it is relatively common in other human groups such Africans (22%) and East 
Asians (10%) populations. This finding may therefore raise doubts about a link of c.-343G>C 
variant to male infertility, since it would imply large disease incidences in Africa and East Asia 
continental regions. 
 
Figure 17 – eQTL data for c.-343G>C (rs58056773) variant. Normalized values of OSGIN1 expression are displayed along the 
Y-axis and the genotypes (homozygous and heterozygous) are displayed on the X-axis. Box plots are shown as median and 25th 
and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. The effect size 
of the eQTLs is computed as the effect of the alternative allele relative to the reference allele. Reference sequence contains 
major allele.  (Figure from www.gtexportal.org/home/). 
 
The p.Val540Ala (rs62640905) variant, a nonsynonymous replacement of two amino acids 
with similar biochemical properties, has been predicted as tolerated (score of 0.06) by SIFT 
and possibly damaging (score of 0.446) by PolyPhen. This SNV shows almost a three times 
higher frequency in SHV cases (fSHV = 0.0541), and a two-fold increase in AST (fAST = 0.0376), 
when compared with in controls (fNMR = 0.0182 and fIBS = 0.0190). Here, the frequency 
increment seen in AST phenotype may be tight connect to SHV because 8 out of 12 cases 
carrying p.Val540Ala display combined SHV and AST phenotypes. Importantly, aside for a 
P-value = 1.1 x10-5 
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possible effect in protein activity, this variant is located in same regulatory region of exon VII 
previously found to harbor a binding site for POLR2A and to contain another possible 
susceptibility variant (Figure 14). 
Other possible candidate variants for male infertility are p.Arg11Gln (rs74478878), 
c.57+213A>C (rs73245092), p.Arg263Arg (rs111436159), p.Phe308Phe (rs201940808), 
p.Pro341Pro (rs142802229) and c.*193G>A (rs534233458), which are all absent from control 
groups (NMR and IBS). The p.Arg11Gln (rs74478878) variant was found  exclusively in a 
single AST case and predicted to have minor functional consequences (classified as tolerated 
low confidence by SIFT  - score 0.36 and as benign by PolyPhen – score 0.00). Although this 
variant is found at extremely low frequencies in European populations (MAF < 0.001) 
according to the largest database of human genetic variation (gnomAD: 
http://gnomad.broadinstitute.org/), in Africans it can reaches nearly 4%. A similar situation 
happens with the intronic variant c.57+213A>C (rs73245092), but with a slightly higher 
frequency in Africans (8%). This SNV was found to be augmented mainly in SHV cases (fSHV 
= 0.0102), still it could not be associated to any functional relevant region. 
The p.Arg263Arg (rs111436159), p.Phe308Phe (rs201940808) and p.Pro341Pro 
(rs142802229) candidate variants, each identified in one single case with SHV and AST 
phenotypes, are located in the same regulatory region of the p.Ala357Ala (rs3743627) 
common variant that spans binding sites for POLR2A and BCL3 transcription factors (Figure 
14). These SNVs have very low estimated frequencies in Europeans (MAF < 0.001 - gnomAD) 
and even lower prevalence in other populations, except for p.Arg263Arg (rs111436159) that 
reaches about 3% in Africans, which may suggest a possible association to male infertility. A 
similar situation occurs with c.*193G>A (rs534233458) variant located in OSGIN1 3’UTR and 
in a sequencing encompassing the same POLR2A binding site (Figure 14). This turn, the SNV 
was only found in two AST cases (fAST = 0.0054), present in Europeans at frequencies bellow 
0.0001 and, so far, absent from other populations. 
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In general, OSGIN1 variants are most frequently associated to AST phenotype, even if 
combined with SHV, which may suggest a more likely contribution of this gene into AST rather 
than SHV. Taking together the collected data of OSGIN1 sequencing variability, 5 variants 
emerged as promising candidates for future studies of male infertility, these include the 
p.Ala357Ala (rs3743627) common variant found to be statistical associated with AST 
phenotype; and the p.Val540Ala (rs62640905), p.Phe308Phe (rs201940808), p.Pro341Pro 
(rs142802229) and c.*193G>A (rs534233458) low-frequency variants found to be 
overrepresented in AST and/or SHV patients, located in functional relevant regions and 
possibly associated with male infertility. Noticeably, all these variants can be correlated with a 
binding site for POLR2A, in some cases also in overlap with BCL3, thus proposing a possible 
effect in male infertility through the regulation of OSGIN1 mRNA expression levels. 
 
4.1.2. OSGIN1 Transcriptional Variation 
To better understand the potential impact of OSGIN1 variability in gene expression, we 
decided to analyze GTEx data concerning the different transcripts, with a greater focus on the 
testis tissue (Figure 18). According to the GTEx panel containing a total of 53 tissues, OSGIN1 
is substantially more expressed in liver followed by adrenal gland and testis. In most of these 
tissues, the canonical transcript (ENST00000393306) is the main OSGIN1 isoform. 
Nonetheless, in the testis along with the canonical isoform expressed at higher levels [median 
transcript per kilobase million (TPM) = 14.480], two other transcripts can be detected 
(ENST00000361711 – median TPM = 4.210 and ENST00000561552 – median TPM = 2.000). 
In our study, for the propose of variant annotation, we relied on a different transcript indicated 
by most databases as the main alternative isoform of OSGIN1 and that could be correlated to 
the WES signal in exon I. Unfortunately, this transcript was recently found to be present only 
at residual levels in testis (ENST00000343939 – median TPM = 0.390) and in most tissues. 
  
FCUP 
A genetic study of male infertility centered in semen hyperviscosity and asthenozoospermia phenotypes 
73 
 
 
Figure 18 – OSGIN1 expression and comparison of ENST00000393306, ENST00000361711, ENST00000561552 and 
ENST00000343939 transcriptional levels. Expression values are shown in TPM (transcript per kilobase million) along the Y-
axis and different tissues are displayed along the X-axis. OSGIN1 is more expressed as the canonical isoform ENST00000393306 
(median TPM = 14.480) than as the isoform ENST00000343939 (median TPM = 0.390), chosen for variant annotation purposes. 
(Figure from www.gtexportal.org/home/). 
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In summary, the transcript used for variant annotation (ENST00000343939) differs from the 
ENST00000361711, the second most expressed transcript, by the presence of exon II, which 
means that candidate variants located on exons I and VII are expected to equally affect both 
gene isoforms (Figure 19). These OSGIN1 isoforms diverge from the canonical transcript 
(ENST00000343939) by the presence of upstream exons and for skipping an alternative 
untranslated exon. Finally, the third most expressed transcript (ENST00000561552) appear 
to be quite atypical OSGIN1 transcript and has been only recognized by Ensembl Gene 
Predictions. Nonetheless, candidate variants located on exon VII are expected to equally 
affect canonic, ENST00000361711 and ENST00000343939 gene isoforms, while SNVs within 
exon I are more likely to impact the expression of the ENST00000343939 and 
ENST00000361711 transcripts. 
 
 
 
 
Figure 19 – Alternative OSGIN1 isoforms as reported in UCSC Genome Browser and Ensembl Genome Browser. The 
ENST00000561552 transcript is only reported by Ensembl Gene Predictor tools while the other 4 appear to consistently describe 
by different databases. The ENST00000343939 transcript differs from the ENST00000361711 transcript by the presence of exon 
II. The three isoforms differ from the canonical (ENST00000393306) by the presence of upstream exons. 
 
Even though OSGIN1 has never been described as implicated in infertility, this gene has been 
reported to encode a protein that regulates the response to OS. Considering, the well-known 
burden of OS in male fertility in connection with critical alterations of reproductive and seminal 
parameters, such as sperm cell membrane LPO, semen low antioxidant capacity of the 
semen, loss of sperm cell membrane fluidity and spermatozoa immobilization (Athayde, et al. 
2007; Aydemir, et al. 2008; Agarwal, et al. 2014; Layali, et al. 2015), a role of OSGIN1 in male 
infertility may be presented as a plausible hypothesis. However, additional studies such as an 
evaluation of OSGIN1 variability in larger cohorts to a molecular characterization of protein 
activity in a reproductive framework are needed. 
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4.2 Evaluation of HLA-DRB5 Association Signal 
In a first attempt, to evaluate the association signal observed in HLA-DRB5 locus, two 
amplicons were designed for Sanger sequencing based on the location of SNVs with most 
significant WES study p-values. These amplicons comprised a segment of 887bp 
(chr6:32489286-32490172) surrounding HLA-DRB5 exon II and a 2238bp fragment 
(chr6:32485172-32487409) spanning from exons III to VI (Figure 11B, in chapter 2). 
Similar to the experimental approach carried out for OSGIN1, we first randomly selected for 
Sanger sequencing 10 infertile cases belonging to the WES cohort. Oddly, most samples 
failed to amplify both fragments in replicated PCR reactions. To overcome this problem of 
HLA-DRB5 amplification, which could be hypothetically correlated with a polymorphic gene 
deletion, we performed a literature search for such variant types in the HLA locus (see chapter 
1). Indeed, in Campbell et al. 2011 work, not only a copy number polymorphism in HLA-DRB5 
leading to a full gene deletion is acknowledged, as the genotypes for several samples from 
the International HapMap Project available at our laboratory are provided (Campbell, et al. 
2011). Therefore, we chose several HapMap samples, more precisely, 10 Europeans, 10 
Africans and 10 Asians, to evaluate the specificity of our PCR methodology in HLA-DRB5 
polymorphism detection. The genotypes for these HapMap samples were concordant with 
Campbell et al. 2011 study, but, again, WES and PCR results were incongruent. The HLA 
locus as a whole is recognized to be a highly diverse system, nevertheless HLA-DRB3-5 
genes are reported to display considerable homology and to be mutually exclusive in the 
human genome (Figure 10, in chapter 1). Here, the occurrence of such copy number 
polymorphism can provide an explanation for the inconsistent WES results (Mosaad 2015; 
Norman, et al. 2017). Precisely, in the HLA-DR sublocus the short-read sequencing methods 
together with the high level of polymorphism and the presence of several paralogue genes 
may have hampered a correct assemblage of WES data (Carapito, et al. 2016). 
Several bioinformatics tools have been developed to deal with HLA locus complexity and to 
address HLA alleles and genotypes using NGS data (Hosomichi, et al. 2015). Unfortunately, 
no tool currently available reports an inference for HLA-DRB5 copy number polymorphism and 
for downstream genotypes (Zhang, et al. 2017). Due to this limitation, we screened HLA-DRB5 
variation for the entire cohort (231 cases and 55 controls), including the 71 infertility cases 
previously covered in WES study, with the following PCR strategy: a first amplicon comprising 
exon II of HLA-DRB5 gene (887bp) and a second amplicon spanning from exon III to VI 
(2238bp). These two amplicons were used to more accurately assess the presence or 
absence of HLA-DRB5 (Figure 20). Then, samples found to display positive results for both 
HLA-DRB5 amplifications were Sanger sequenced for exon II, which is the preferred region 
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for HLA class II allele inference. Finally, IPD-IMGT/HLA Database was used to compare our 
own results with other HLA deposited sequences to infer the HLA-DRB5 alleles. 
 
 
 
 
 
 
 
Figure 20 – HLA-DRB5 genotyping using a copy-specific PCR strategy. Amplification of 887 bp fragment containing exon II 
(lanes 2 to 6) and amplification of 2238 bp fragment including exon III to VI (lanes 7 to 11). Lanes 2 and 7 and lanes 4 and 9 
correspond to HLA-DRB5 positive samples while lanes 3 and 8 and lanes 5 and 10 correspond to HLA-DRB5 negative samples. 
Lanes 6 and 11 correspond to negative control. MW – molecular weight. 
 
In parallel, we applied the HLA*PRG:LA software to the analysis of HLA locus diversity in our 
WES dataset of 71 infertile cases, and to a second WES panel containing the 55 controls that 
was only available in an advanced phase of this study. Briefly, the HLA*PRG:LA is a 
bioinformatics tool specific for HLA typing that uses as raw material the reads generated by 
deep sequencing and instead of performing the assembling to a single human reference 
sequence it uses a population framework as reference (Dilthey, et al. 2016). This way, we 
were able to obtain the allele group information for HLA-DRB1, HLA-DRB3 and HLA-DRB4, 
which helped us to confirm the presence or absence of HLA-DRB5 and to additionally infer 
HLA-DRB5 allele groups. More specifically, due to the extensive LD present in the HLA locus, 
HLA-DRB5*01 tends to segregate in the same chromosome with to HLA-DRB1*15 allele, 
whereas HLA-DRB5*02 more often segregates with to  HLA-DRB1*16 allele (Table VIII). 
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Table VIII – Possible haplotype configurations of HLA-DRB1 and HLA-DRB5 allele.  
HLA-DRB1 Allele 
Groups 
HLA-DRB1 
Specific Alleles 
HLA-DRB5 Allele 
Groups 
HLA-DRB5 
Specific Alleles 
HLA-DRB1*15 
:01:01 
HLA-DRB5*01 
:01:01 
:16 
:02:01 
:02 
:08N 
HLA-DRB1*16  HLA-DRB5*02 
:02 
:05 
:06 
 
4.2.1 HLA-DRB5 Allelic Variability and Association to Male Infertility 
As previously mentioned, we analyzed HLA-DRB5 variability by combining the results from: 
1) PCR amplification of two HLA-DRB5 fragments, a first one for exon II (887bp) and second 
for exons III to VI (2238bp); 2) Sanger sequencing of HLA-DRB5 exon II and sequence 
identification using IPD-IMGT/HLA Database; and 3) WES data typing using HLA*PRG:LA 
tool. In the end, the collected HLA-DRB5 variability was used to evaluate its association to 
SHV and AST phenotypes. 
In our dataset, we found that the presence of HLA-DRB5 is less common in both cases and 
controls than its absence (Table IX). Only 45 out of 231 infertile cases and 8 out of 54 controls 
were found to carry copies of this gene in hetero- or homozygosity (fINF = 0.1039 and fCON = 
0.0741). Despite the slightly lower frequency observed in controls, this is not enough to reach 
statistical significance and it is more likely attributed to differences in sampling size than to 
any correlation to male infertility. Concerning the variability within HLA-DRB5, a total of two 
allele groups (HLA-DRB5*01 and HLA-DRB5*02) and 6 specific alleles were identified (Table 
IX). The specific alleles HLA-DRB5*01:11, HLA-DRB5*02:05 and HLA-DRB5*02:12 were 
inferred unambiguously in contrast to HLA-DRB5*01:01:01/*01:16, HLA-DRB5*01:02/*01:08N 
and HLA-DRB5*02:02/*02:06, which were inferred with some level of uncertainty – genetic 
data could fit two different specific alleles. 
 Table IX – HLA-DRB5 variability in infertility cases and controls. 
 
  
 
HLA-DRB5 
HLA-DRB5 alleles 
MAF - cases 
MAF - 
controls 
Cases 
N = 231 
Controls 
N = 541 
WES Sanger WES & Sanger 
NRM 
N = 541 Total 
N = 71 
AST 
N = 45 
SHV 
N = 61 
Total 
N = 160 
AST 
N = 143 
SHV 
N = 50  
Total 
N = 231 
AST 
N = 188 
SHV 
N = 111  
Presence 0.1039 0.0741 
HLA-
DRB5*01 
:01:01/:16 0.0563 0.0556 0.0574 0.0656 0.0629 0.0700 0.0628 0.0612 0.0631 0.0556 
:02/:08N 0.0070 0.0111 0.0000 0.0156 0.0175 0.0300 0.0129 0.0159 0.0135 0.0000 
:11 0.0000 0.0000 0.0000 0.0031 0.0035 0.0000 0.0022 0.0027 0.0000 0.0000 
Total 0.0633 0.0667 0.0574 0.0843 0.0839 0.1000 0.0779 0.0798 0.0766 0.0556 
HLA-
DRB5*02 
:02/:06 0.0282 0.0000 0.0328 0.0188 0.0175 0.0300 0.0216 0.0133 0.0315 0.0185 
:05 0.0070 0.0111 0.0082 0.0000 0.0000 0.0000 0.0022 0.0027 0.0045 0.0000 
:12 0.0000 0.0000 0.0000 0.0031 0.0035 0.0000 0.0022 0.0027 0.0000 0.0000 
Total 0.0352 0.0111 0.0410 0.0219 0.0210 0.0300 0.0260 0.0187 0.0360 0.0185 
Absence 0.8961 0.9259 - 0.9015 0.9222 0.9016 0.8938 0.8951 0.8700 0.8961 0.9016 0.8874 0.9259 
MAF, minor allele frequency; WES, whole-exome sequencing; AST, asthenozoospermia; SHV, semen hyperviscosity; NRM, normozoospermia; N, number of 
individuals 
1 One sample was excluded from the analysis due to missing or uncompleted genotypes. 
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This ambiguity mainly results from exon II being the only sequenced region for HLA-DRB5 
allele typing. To accomplish a full allele annotation, we would need to extend our sequencing 
to other coding and non-coding regions and use the IPD-IMGT/HLA Database to compare the 
results with deposited allele sequences. 
In overview, for those individuals carrying HLA-DRB5 we could further characterize their 
variability and evaluate a possible association to SHV and AST phenotypes (Table IX). The 
HLA-DRB5*01 was found to be more prevalent than HLA-DRB5*02 in any of the analyzed 
datasets, and among them we could identify two more frequent specific alleles, HLA-
DRB5*01:01:01/*01:16 and HLA-DBR5*02:02/*02:06, respectively. No statistical differences 
were observed between cases and controls. In three infertile cases combining SHV and AST 
phenotypes we could detected another specific allele (HLA-DRB5*01:02/*01:08N) not found 
in controls. However, this can be explained by the limited number of HLA-DRB5 positive 
controls rather than a correlation to male infertility. The remain alleles were rare and identified 
in single cases. In the end, we did not find any association of HLA-DRB5 copy number 
polymorphism with male infertility, nor for HLA-DRB5 alleles. 
The HLA locus encodes cell-surface glycoproteins that are specialized for immunity functions 
(Kamidono, et al. 1980). Several examples of association of HLA locus to male infertility are 
described in literature in particular for NOA phenotype (Zhao, et al. 2012; Jinam, et al. 2013; 
Hu, et al. 2014; Tu, et al. 2015; Zou, et al. 2017). Nevertheless, a correlation of HLA-DRB5 
variability has never been explored in the framework of male infertility. So far, HLA-DRB5 has 
been only connected to other diseases, such as interstitial lung disease (ILD), systemic lupus 
erythematous (SLE) and multiple sclerosis (MS) (Odani, et al. 2012; Quandt, et al. 2012; Wu, 
et al. 2014). 
Our currents findings point out the WES signal of HLA-DRB5 as an artifact connected with the 
copy number polymorphism and high sequence homology, to a lack of correlation between 
the presence of HLA-DRB5 and AST and SHV phenotypes. However, to address if any of the 
alleles may confer a larger susceptibility to disease and SHV and AST phenotypes, we would 
need considerable larger sample sizes. 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
5. Conclusions 
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The current study aimed to test the contribution of OSGIN1 and HLA-DRB5 variability into 
SHV and AST male infertility phenotypes, using a cohort of Portuguese patients and controls, 
and by applying PCR and Sanger sequencing techniques combined with classic statistical 
approaches for association studies. In a global perspective, this study allowed to conclude 
that: 
 
1. The analysis of regions with repetitive elements, copy number variation, and sequences 
with high polymorphism levels and homology, through high-throughput sequencing 
methods should always be performed with caution, as illustrated by the discrepancies 
between the results from WES and Sanger datasets for OSGIN1 and HLA-DRB5. 
  
2. OSGIN1 variation seems to have a stronger contribution to AST susceptibility then to SHV 
phenotype, which may possibly be related to OSGIN1 mRNA expression and 
consequently, with oxidative stress regulation. This hypothesis is supported by the 
presence of a common variant, p.Ala357Ala (rs3743627),  statistically associated with 
AST phenotype, together with 4 overrepresented low-frequency variants, all located in a 
POLR2A binding region. 
  
3. Neither HLA-DRB5 copy number polymorphism nor any specific allele was found to be 
associated with male infertility, independently of the considered phenotype. 
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